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Genomic analysis of human neuroblastoma cells in response to paraoxon exposure
Chairperson: Katie M. George, Ph.D.
Organophosphates (OP) belong to a diverse class of chemical compounds with
applications for pesticide use as well as nerve gas agents. OPs are well-characterized
neurotoxicants whose primary molecular target is acetylcholinesterase (AChE). By
covalent modification o f the enzymatic active site, OPs inhibit the hydrolytic function o f
AChE, resulting in acute toxic symptoms o f hypercholinergic stimulation. We
hypothesize that OPs are highly reactive compounds capable of interacting with other
cellular proteins and eliciting additional, non-AChE-associated effects in neuronal cells.
To begin to address this question, a human neuroblastoma cell line, SH-SY5Y, was
exposed to 10 nM paraoxon (PX) for 3, 8, and 24 hours and changes in gene expression
were analyzed using the Human Tox cDNA microarray chip. From the microarray data,
a select group of genes, including ECMl and ODCl, that showed differential expression
following PX exposure were analyzed by semi-quantitative polymerase chain reaction
and immunoblot. Although microarry data was not confirmed with RT-PCR, ECMl
showed increased protein expression following PX exposure. A comprehensive analysis
of the microarray data using GoMiner software identified a number o f possible cellular
processes targeted by PX. One of these processes, cellular proliferation, was further
characterized and it was demonstrated that 10 nM PX significantly induces proliferation
in SH-SY5Y cells.
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Chapter 1
INTRODUCTION

The development of organic phosphorus (organophosphates, OP) compounds
originated during the middle of the 19*'’ century with Jean Louis Lassaigne’s analysis of
the reaction of alcohol with phosphoric acid. The possible use of OP’s as insecticides or
nerve agents was realized in 1936 through the work of German chemist Gerhard Schrader
(Rusyniak and Nanagas 2004). Schrader was in charge o f developing new and improved
insecticides when he created the compound Ethyl N,N-dimethylphosphoramidocyanidate
(tabun) 1 (Figure 1.1), which became better known as nerve agent GA. Because of the
time period, much of the continued effort in developing OPs was steered towards
compounds that could be used as chemical warfare agents, although fully understanding
the potential of OPs as insecticides. The potential of OPs to be used as chemical agents
led to the German Ministry of Defense classifying Schrader’s OP compounds as
confidential which initially prevented their development as commercial insecticides.
Further work by Schrader resulted in the additional nerve agents 2-( fiuoro-methylphosphoryl)oxypropane (sarin, GB) 2 and 3-(fluoro-methyl-phosphoryl)oxy-2,2dimethyl-butane (soman, GD) 3 (Talley 2001).
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Figure 1.1 Neurotoxic Organophosphorus Chemicals

1: Tabun

2: Sarin

3: Soman

Many of these OP compounds have been stockpiled for years as neurotoxic agents
or nerve gas for military use (Caglioti 1983). Despite an international ban on the use and
production o f these neurotoxic compounds, there is evidence that sarin 2 was used by
Iraq during its conflict with Iran and during the first Gulf War (Black 1993). This has led
to the suggestion that exposure to sarin 2 may be a contributing factor to the so-called
Gulf War Syndrome (Ember 1996). Sarin 2 was also used by terrorists in an attack on a
Tokyo subway in 1995 which resulted in twelve deaths and more than 5,000 casualties
(Satoh and Hosokawa 2000).
While the early development of OP’s pursued differential nerve agents for
military warfare, a new group of compounds came to the forefront for use as insecticides.
In 1939 Paul Muller won the Nobel Prize for the creation of the organochlorine
dichlorodiphenyltrichloroethane (DDT). Organochlorine compounds quickly became the
most widely used pesticides around the world (Rusyniak and Nanagas 2004). The use of
organochlorines as agricultural pesticides resulted in an effective pesticide with low
human toxicity. With continued use however, the potential environmental impact of
organochlorines led to their own demise after the realization DDT and its metabolites
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bioaccumulate and biomagnify in the ecosystem and body tissue (Galloway and Handy
2003). By the 1970’s, the use of organochlorines as insecticides were either legally
banned or heavily restricted, resulting in an increased use and production of OPs, and
eventually OPs becoming the preferential insecticide used around the world.
OP compounds represent the largest group of chemical insecticides in use today
with over half of the eight billion dollar (US dollars) insecticide world market being
represented by OPs (Casida and Quistad 2004). OPs have been a critical part of
increasing production of many crops including com, wheat, and cotton, as well as being
an essential part of plant and lawn care in both the residential and commercial setting
(EPA 1999). Additionally, certain OPs have been instrumental in the protection of public
health against such mosquito-bome diseases as malaria, dengue fever, and encephalitis
(EPA 1999). The demonstration by Schrader and coworkers that OP compounds exhibit
insecticidal activity led to the first commercially developed OP, Bladen, in 1944 (Eto
1974). Further development of OPs as insecticides led to the production of thousands of
chemically different OP compounds. Currently, approximately 150 different OPs are in
use accounting for roughly 60 million pounds of OPs being applied to roughly 60 million
acres of agricultural land on a yearly basis. Another 17 million pounds of OPs are used
non-agriculturally for the protection of human health and livestock (EPA 1999). The
structures of some common OP insecticides are shown in Figure 1.2.
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Figure 1.2 Structure of some commonly used organophosphorous pesticides
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Organophosphorus compounds are neurotoxic agents whose main mechanism of
action is the inhibition of serine hydrolases, the most critically of which is the widely
distributed nervous system enzyme acetylcholinesterase (AChE; EC 3.1.1.7) (Fukuto
1990; Carlson et al. 2000; Kardos and Sultatos 2000; Duysen et al. 2001; Ray and
Richards 2001; Hong et al. 2003; Casida and Quistad 2004; Chambers and Oppenheimer
2004; Kamanyire and Karalliedde 2004; Rusyniak and Nanagas 2004). The covalent
modification of the active site serine by an OP causes the inhibition of AChE, blocking
the hydrolytic function of the enzyme. The acute toxic symptoms of AChE inhibition are
attributed to the over stimulation of acetylcholine (ACh) receptors (generally muscarinic;
mAChr) in both the nervous system and effector organs (Ma et al. 2003).
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Cholinergic hyperstimulation following OP poisoning results in excessive
glandular secretions and the well characterized clinical symptoms represented by the
mnemonic word SLUDGE; Salivation, Lacrimation, Urination, Defecation, Gastric
secretions, and Emesis (Rusyniak and Nanagas 2004). In addition to the acute symptoms
of toxic OP insult, three other unique pathologies have been detailed, separate from the
cholinergic effects of OPs. The “intermediate syndrome” typically originates one to three
days after the resolution o f the cholinergic effects, characterized by a muscular weakness
which affects the limbs, respiratory muscles, and muscles of the neck. Recovery of
muscle use generally happens five to eighteen days following the onset of symptoms
(Rusyniak and Nanagas 2004). In response to certain OP’s, a second symptomology
develops one to four weeks post-exposure, long after the cholinergic signs have subsided.
This toxicity is known as organophosphate-induced delayed neuropathy (OPIDN) (Hong
et al. 2003; Kamanyire and Karalliedde 2004; Costa 2006). Symptoms of OPIDN
include a weakness of peripheral muscles in the hands and feet followed by a variable
degree of sensory impairment. The third neurotoxic syndrome associated with OP
exposure is a chronic neurological deficit that appears months to years after exposure.
This syndrome, termed organophosphate-induced chronic neurotoxicity (OPICN),
exhibits signs of cognitive deficits in such areas as memory, concentration, and problem
solving (Damodaran et al. 2006). OP exposure has also been linked to a number of noncholinergic illnesses including cancer, pulmonary toxicity, Parkinson’s and vision loss
(Imamura T 1988; Dementi 1994; Pogoda and Preston-Martin 1997; Senanayake 1998;
Bhatt MH 1999; Meinert et al. 2000; Lotti and Moretto 2005).
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While the clinical symptoms of OP toxicity appear to be well-understood, the
cellular and molecular mechanisms of the toxicities that each OP compound propagates
are far from figured out. The naïve hypothesis that all OP toxicity is caused by a similar
mechanism, the inhibition of AChE, is carefully being replaced with a hypothesis that OP
compounds interact with a multitude of specific molecular targets and cellular pathways
that contribute to a wide variety of clinical symptoms (Costa 2006). Elucidation of the
principal biochemical mechanisms and cellular pathways (cholinergic and noncholinergic) induced by OP exposure could result in improved assessment of health risks
associated with OP exposure.
A detailed discussion of OP exposure is needed to further define the limited
knowledge of the mechanisms of OP toxicity. The following chapter o f the thesis is
divided into three parts; 1) A detailed description o f organophosphates, 2) The
mechanism of AChE, NTE, and serine hydrolase inhibition following OP insult, and
finally, 3) a review of research involved in delineating the secondary targets (non-serine
hydrolases) of OPs.
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Chapter 2
BACKGROUND
The wide spread use of organophosphates as insecticides plays a critical role in
the production of the world’s crops. It has been estimated that nearly half o f all produced
crops in the world would be lost to the devastating effects of insects and other pests if
pesticides were not applied. Even with widespread use of pesticides within the United
States, one-tenth of the crops are destroyed each year resulting in a $20 billion dollar loss
(Talley 2001). OPs also play an important role as insecticides in the non-agricultural
setting as well. OPs are used on lawns, gardens, flowers and even pets. Despite the
recognized fact that organophosphates are neurotoxic agents, the importance of them as
insecticides leads to their continued production and use. An understanding o f OP
chemical structure and different chemical characteristics is an important first step in the
process of gaining an insight into OP action on biological systems.
Organophosphate structure and activity
The simplest representation of an OP is a phosphorus (P) atom that is
tetracoordinate and pentavalent (Mileson et al. 1998). Three of the groups attached to the
P are bound by a single bond while the fourth substituent is attached by a double bond.
This general structure can be represented by Figure 2.1
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Figure 2.1 General structure of an organophosphate
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RI and R2 are generally alkoxy groups (R1,R2 = O-Methyl or O-Ethyl), while X
is the most sensitive to hydrolysis during phosphorylation, and as such, has been termed
the “leaving group”. Most OP insecticides are phosphorothionates, compounds that
contain a P=S (sulfur) bond. For phosphorothionates to become active, the P=S must
first be converted to an oxon (P=0), resulting in the highly reactive phosphate OP (four
oxygen groups bound to the phosphorous). Other subclasses of OPs include
phosphorodithioates which are similar to phosphorothionates but with the leaving group
oxygen replaced with a sulphur. A phosphate with two R group oxygens, a sulfur and a
leaving group nitrogen (N) are phosphoramidates.
Although OPs share a common mode of action, the inhibition of AChE, they are a
chemically diverse group of compounds that also exhibit a variable toxic effect. The
chemical reactivity of OPs is dependent on the chemical structures and different
substituents attached to the phosphorus. The electrophilicity of the phosphorus is the
determining factor in reactivity and is generally determined by the chemical makeup of
the leaving group, X. Structure activity relationships between different OPs have shown
a direct link between the anticholinesterase activity and the reactivity o f the phosphorus
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molecule (Fukuto 1990). The more electron-withdrawing groups on the leaving group
that are attached to the phosphorus, the more reactive the compound becomes, while
electron-donating groups on X diminish the activity o f the OP. Electron withdrawing
groups remove electrons from the phosphorus and make the P-X bond more susceptible
to nucleophilic attack by the hydroxyl group o f the serine during phosphorylation. The
steric properties o f the alkyl chains also influence the OP’s ability to phosphorylate.
Increased chain length and or increased branching o f the R1 and R2 groups markedly
decreases reactivity o f the OP (Fukuto 1990).
Conversion o f thionates to oxons
While high chemical reactivity (i.e. phosphorylation o f serine hydroxyl moiety) of
an OP is dependant on the P = 0 bond, most insecticides contain the P=S linkage. The
P=S bond is a relatively stable bond and is not as polarized as the P = 0 due to the lower
electronegativity o f the sulphur group. The potent insecticidal activity o f OPs with the
P=S bond is due to the metabolic activation o f the P=S into P = 0 by metabolic oxidation
(Dauterman 1971). The metabolic transformations o f OP’s have been the subject o f
extensive research. Fifteen years ago it was believed this reaction was mediated by the
mixed function oxidases (MFO), a ubiquitous enzyme system responsible for the
oxidation o f xenobiotics in animals (Fukuto 1990). Further research more carefully
defined the roles of these MFOs, the cytochrome P450 family of enzymes (CYPs).
Although there are many gaps in the knowledge of the exact CYP involved in the
reaction with each unique OP, the available data point toward a complex picture. The
CYPs involved in the oxidative désulfuration o f P=S to P = 0 show unique substrate
specificities. The insecticide parathion is bioactivated to the oxon, paraoxon (PX) by the
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CYP3A4/5 and CYP2C8 while diazinon is activated by CYP2C19 (Kappers et al. 2001;
Mutch et al. 2003). Certain CYPs have also been shown to be involved in different
transformations (non-activation reactions) o f OPs such as, oxidative dearylation,
oxidative dééthylation, and the reduction o f nitro groups on OP side chains (Costa 2006).
CYPs also play an important role in the metabolic deactivation o f O P’s once they become
oxons.
Chemical breakdown of OPs
The degradation of OPs occurs in both biological systems as well as in the
environment. OPs as a class are a chemically reactive and rather unstable class o f
compounds. All OPs are tertiary esters which make them susceptible to hydrolytic
degradation. Cleavage o f any o f the bonds can occur by both chemical and enzymatic
cleavage which results in detoxification products (Fukuto 1990). OPs in the environment
are readily hydrolyzed in soil, sediment, or surface water (Walker 2001). Relatively
quick hydrolytic cleavage o f OPs within the environment into non-toxic products is one
o f the main reasons OPs gained favor as insecticides over the more chemically stable
organochlorines, which tend to bioaccumulate. Once a thionate (insecticide) becomes an
oxon, biological degradation occurs via one or more o f the following pathways,
cytochrome P450 deactivation, catalytic hydrolysis, and/or non-catalytic hydrolysis.
The CYP family plays an instrumental role in the enzymatic degradation of OPs
within a biological system. CYPs, which have been shown to be involved in the
metabolic activation o f OPs, have also been implicated in the deactivation. CYP2B6 has
been shown to oxidize chlorpyrifos while also degrading parathion into the non-toxic
products p-nitrophenol and diethylphosphorothioic acid (Hodgson 2003). Catalytic
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hydrolysis o f oxon OPs happens by way o f a number of enzymes known as the
phosphotriesterases, or A-esterases. Early studies by Aldridge discovered a group o f
enzymes that hydrolyze aromatic compounds and certain OPs such as paraoxon (Aldridge
1953). These enzymes were named A-esterases and could not be inhibited by OPs.
Further research into the A-esterases and their detoxification o f OPs resulted in the
characterization o f the A-esterase paraoxonase. Studies have shown that purified
paraoxonase injected into animals increases their resistance to the toxic effects o f OPs
(Main 1956; Costa et al. 1990). A second group o f esterases were also discovered that
were important in the detoxification o f OPs. However, compared to the A-esterases,
these serine esterases were shown to be inhibited by OPs and were named the Besterases. The B-esterases are unable to hydrolyze OPs, but by becoming inhibited and
covalently bound to the OP, remove the OP from the plasma. Identified B-esterases
include carboxylesterases, butyrylcholinesterase (BuChE), and the widely researched
acetylcholinesterase (AChE). After the discovery that AChE is the primary target o f OPs
within a biological system, the focus o f OP research was placed squarely on the
mechanism and consequences o f this interaction. The next section will focus on the
mechanism o f inhibition o f AChE by OPs, as well as the inhibition o f other major serine
hydrolases.
OP inhibition of AChE
Acetylcholine (ACh) is one o f the major neurotransmitters in the peripheral and
central nervous system. While many other neurotransmitters are removed from the
synaptic cleft by re-uptake into the cell, the majority o f ACh is hydrolyzed into the
inactive products choline and acetic acid by the enzyme AChE (Rotundo 1983; Massoulie
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et al. 1993; Massoulie et al. 1998; Rotundo et al. 1998). AChE is one o f the fastest
enzymes known with an extremely high catalytic efficiency and turnover rate exceeding
IxlOM molecules o f ACh per second (Quinn 1987; Jennings et al. 2003). The active site
serine located within the gorge o f AChE is the main player o f the hydrolysis reaction and
is responsible for the enzymatic cleavage o f ACh. AChE has been studied extensively
for many different reasons for almost a century now. Areas o f AChE research include as
an enzyme, a therapeutic venue, a marker o f cholinergic neurons, cell to cell interactions
and as a target of pesticides and nerve agents, namely organophosphates (Rotundo 2003).
Research into AChE and OPs concluded that this same active site serine is also the target
o f organophosphates.
The mechanism o f phosphorylation o f the active site o f AChE can be divided into
three parts. The first action is the phosphorylation ( 1 ), followed by one o f two exclusive
steps, either reactivation ( 2 ) (dephosphorylation), or a chemical reaction termed “aging”
( 3 ), illustrated in figure 2.2.
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Figure 2.2 Inhibition o f AChE by organophosphates
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Organophosphates are substrates of AChE and their hydrolysis results in the
phosphorylation o f the active serine, effectively blocking the action o f the enzyme on its
physiological substrate, ACh (1). The resulting chemical bond between the phosphorus
and active site hydroxyl group is much more stable than the bond between the carbonyl
carbon o f ACh and active site. Depending on the structure o f the OP, the
phosphorylation can last from a few h to several days (Gallo MA 1991). Following
phosphorylation, the phosphorus-enzyme bond can be hydrolyzed by water or an oxime
(2). While water is a weak nucleophilic agent, highly nucleophilic oximes such as 2PAM (pralidoxime) can readily facilitate the reactivation o f phosphorylated AChE
(Chambers and Oppenheimer 2004). An alternative fate results when the phosphorus
group attached to the active site is dealkylated, resulting in the loss o f one o f the alkyl
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groups (RI or R2), the enzyme-OP complex becomes “aged” (3). Aging results in an
OP-AChE conjugate that contains a phosphate oxyanion that is unable to regain enzymic
activity. Dealkylation (aging) strengthens the phosphorus-enzyme bond and AChE is
irreversibly inhibited (Mileson et al. 1998).
Non-AChE esterase targets o f OPs
Analogous to the inhibition o f AChE by OPs, other serine hydrolases can be
inhibited by OPs including butyrylcholinesterase (BuChE), carboxylesterases (CE), and
neuropathy target esterase (NTE), the enzyme implicated in organophosphate-induced
delayed neuropathy (OPIDN). The essential feature o f the serine hydrolases is the
nucleophilic serine that attacks the OP (O'Neill 1981). The inhibition and subsequent
dephosphorylation (or aging) o f these serine hydrolases depends on the nucleophilicity,
lipophilicity, and stereospecificity o f the OP and the positioning and nature o f the active
site serine (Casida and Quistad 2004).
It was originally thought that both BuChE and the carboxylesterases (CE) did not
serve an important physiological function in the body except as xenobiotic metabolizing
enzymes, and that their elimination had little if any negative impacts on physiology or
health (Chambers and Oppenheimer 2004). These enzymes were thought to act as
prophylactics in the protection o f the “important” enzyme AChE by becoming inhibited
and subsequently destroying the OP compound by blocking the OP from further
phosphorylation. Certain CEs have been shown to be more sensitive to OPs than AChE
which would support the idea o f CEs acting as prophylactics (Ray and Richards 2001).
Not surprisingly, further research into the roles o f BuChE and CE attributed important,
specific functions to these enzymes outside o f their role as prophylactics. The enzyme
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BuChE has been shown to be important in the hydrolysis o f choline and non-choline
esters including the neurotransmitter ACh. BuChE also enhances the activity of certain
proteases including trypsin and has been implicated in cellular proliferation and neurite
outgrowth during neuronal development (Darvesh et al. 2003). CEs are ubiquitous
enzymes that cleave carboxylic esters into their corresponding carboxylic acids and
alcohols. Mammals have over 300 different CEs that have different specificities for a
variety o f substrates. CEs were originally believed to be important in only drug and
xenobiotic metabolism but have recently been recognized for their role in the processing
o f endobiotic compounds (Redinbo and Potter 2005). This includes functioning in
cholesterol homeostasis and fatty acid metabolism. With new roles being discovered for
serine hydrolases that are important to the physiology of the cell, research into the
inhibition o f these hydrolases following OP exposure becomes more critical. When these
hydrolases become inhibited, there is a possibility that other cellular pathways and up- or
downstream targets are affected.
Following exposure to OPs, there is a clear toxicological description o f the acute
cholinergic crisis that occurs after with the inhibition of AChE. The clinical symptoms o f
OPIDN have also been fairly well documented that occur well after the cholinergic crisis.
Research into the mechanism o f OPIDN postulated that the inhibition (and subsequent
aging) o f a novel enzyme, neuropathy target esterase (NTE) by certain OPs is the cause
o f OPIDN (Barrett et al. 1985). Yet, while NTE has been implicated as the initiator of
OPIDN following its inhibition, the physiological role o f NTE and its involvement in the
manifestation o f OPIDN have yet to be fully characterized. NTE has been shown to have
a physiological role in lipid metabolism and homeostasis (Zaccheo et al. 2004). The
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phosphorylation and aging o f NTE happens within hours o f exposure, yet the clinical
symptoms o f OPIDN manifest 2-4 weeks afterwards. The clinical symptoms attributed to
OPIDN begin with a tingling and loss o f sensation in the hands and feet. Cramping pains
in the legs ensue, followed by rapidly progressive muscle weakness of the lower limbs.
Severe cases include loss o f the ability to coordinate muscle movements and eventual
paralysis o f lower and upper extremities. Patients may eventually regain function o f
limbs with diminished operation (Rusyniak and Nanagas 2004). Pathological studies
after NTE inhibition but before clinical symptoms, demonstrated degeneration o f axons
and their terminals as well as spinal cord atrophy. The deterioration of the peripheral
axons is directly proportional to the length o f the specific axon (Rusyniak and Nanagas
2004). Interestingly, the symptoms o f OPIDN appear with only a select group o f OP’s.
OPIDN symptoms are also unrelated to the cholinergic and intermediate symptoms, occur
well after those symptoms have subsided, and cannot be attributed to the inhibition of
AChE, which occurs with every type o f OP compound (Costa 2006). With the growing
body o f research on NTE and OPIDN, the mechanism and pathways from the progression
o f NTE inhibition to axonal degradation to clinical symptoms of OPIDN remain
undefined.
Additional non-ACh£, non-NTE syndromes
The clinical symptoms o f the “intermediate syndrome” following OP exposure,
which are characterized by a weakness o f respiratory, neck and proximal limb muscles,
have not been directly correlated with a molecular target. The signs appear after
cholinergic resolution but before OPIDN, yet the only hypothesis concerning the effects
o f the intermediate syndrome is cholinergic receptor desensitization due to prolonged
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cholinergic stimulation (Lotti 2001). Again, the exact mechanism o f the syndrome is
unclear.
To further confound the research o f mechanisms o f symptoms associated with OP
exposure, is the somewhat controversial research studying the pathology o f the chronic
neurological conditions persisting long after the OP insult. Studies have shown different
cognitive effects following OP exposure including deficits in memory, problem solving,
and concentration (Rusyniak and Nanagas 2004). There have also been reports of
psychiatric problems such as depression and anxiety. However, not all groups studying
cognitive effects following OP exposure have shown the same associations. With this
multitude o f research describing different clinical syndromes associated with OP
poisoning, and the firm belief that these symptoms cannot be adequately explained solely
by the inhibition o f AChE or NTE, scientific studies began to investigate secondary
targets and pathways affected by OP compounds.
Secondary targets of OP exposure
It is difficult to make generalized comments about the mechanistic action o f OPs
on biological systems outside the inhibition o f AChE. Many studies have been done on
different model systems with a wide array o f different OPs at all types of concentrations
resulting in a multitude of responses. Because there are many different OPs and
concentrations used in OP research, it is important to not make a broad generalization
about all OPs when discussing secondary targets. However, there is a significant quantity
o f research that points to the fact that OPs do affect secondary targets and pathways
within the cell. The next section will discuss four different broad groups o f targets
presented here as secondary targets o f OPs. The first section will be unique DNA /
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mRNA / protein products that are modulated, altered, or blocked by OPs. The next
section will look at certain well established pathways in the cell affected by OPs. The
affect o f OPs on both the immune system and cognitive behavior will make up the last
two parts o f the discussion.
DNA: Certain OP methyl esters have been shown to damage DNA through
méthylation. This alkylation o f DNA can cause point mutations within the DNA strand,
opening the strand to possibilities o f mismatched pairs. The OP trichlorfon was
demonstrated to inhibit the enzyme O^-methylguanine-DNA methlytransferase which is
involved in the catalytic repair o f O^-methy 1guanine (Badawi 1998). Inhibition of this
enzyme further complicates the effect o f DNA alkylation.
Gene expression changes: Cholinergic gene expression changes are generally an
indirect effect resulting from increased levels o f ACh following AChE inhibition by OPs.
Expression levels o f AChE mRNA was monitored at different time-points following the
injection o f the nerve agent Sarin (0.5x LD 5 0 ) into rats (Damodaran et al. 2003). AChE
showed differential expression in different regions o f the brain following sarin treatment
in comparison to control. Two hours following treatment, AChE was induced almost
three-fold with a return to basal level by 24h.
Mouse brain slices exposed to diisopropylfluorophosphate (DFP) showed
overexpression of c-fos (early response transcription factor), choline acetyl transferase
(ChAT), and vesicular ACh transporter (VAChT) (Kaufer et al. 1999).
OPs are able to directly inhibit steroid hormone levels by blocking
adrenocorticotropin and cAMP-stimulated steroidogenesis (Civen et al. 1977). More
recent investigations indicate OPs may block steroidogenesis by blocking transcription o f
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the steroidogenic acute regulatory (StAR) gene (Walsh et al. 2000). The StAR protein
mediates the rate-limiting step in steroidogenesis and its decreased expression can lead to
impaired reproductive function.
Protein modulation: The response o f cholinergic receptors, both muscarinic
(mAChR) and nicotinic (nAChR), has also been studied in response to OPs. Because of
the different model systems (jn vitro and in vivo) and different types and concentrations
o f OPs used, it is difficult to make a generalized summary about the effects o f OPs on
cholinergic receptors. Nevertheless, OPs directly modify cholinergic receptor activity
(activating and blocking), downregulate receptor number (both directly and indirectly
through the inhibition o f AChE), and cause differential regulation o f both nAChR and
mAChRs mRNA (directly and indirectly) (Jett et al. 1993; Khan et al. 2000; Casida and
Quistad 2004).
The phosphorylation (activation) of Ca^VcAMP response element binding protein
(CREE) was shown to occur following low dose exposure (doses that do not inhibit
AChE) o f primary cortical neurons with chlorpyiifbs (Schuh et al. 2002). CREE is an
important activator o f gene transcription and is involved in the control of many cell
processes, including hormone synthesis in endocrine cells and the formation of long-term
memory in neurons (Alberts 2002).
The nerve agent Soman was shown to directly inhibit the release of
norepinephrine from rat brain cortical slices and was suggested that it was acting through
direct action at NMDA receptors (Tang and Cassel 1998).
High non-lethal doses o f malathion induced variable amounts of cell roimding and
shrinkage as well as progressive loss of cell-cell and cell-substrate adhesion in cultured
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breast cancer cells (Cabello et al. 2003). This toxicological phenotype was found to be
due to the decreased expression o f two different epithelial adhesion proteins, E-cadherin
and B-catenin. At lower concentrations o f malathion, increased expression o f two small
GTPases (Rho and R a d ) were measured.
Cellular pathways: OPs have been demonstrated to alter cellular pathways.
Calcium (Ca^^ is involved in many different aspects o f the cell including functioning as
a ubiquitous intracellular messenger and integral part o f neurotransmission. Ca^^
homeostasis within the cell is an important part o f signaling pathways in the cell and is
directly modified by OPs. Sun et al. showed low levels of PX (0.1 nM-10 nM) exposure
significantly increased basal levels o f Ca^^ in human parotid salivary cells (HSY) (Sun et
al. 2000). Pre-exposure o f the HSY cells to nanomolar levels o f PX also increased Ca^^
release from 1,4,5-inositol-triphosphate (Ip 3 )-sensitive stores following addition of a
muscarinic agonist, suggesting PX increases the sensitivity o f IP 3 receptors (Sun et al.
2000). It was hypothesized that PX is acting directly on these downstream targets o f the
phosphoinositide signaling pathway.
High concentrations (mM) o f PX have been shown to cause a transient increase in
intracellular Ca^^ in SK-N-SH-SY5Y cells (Hong et al. 2003). However, this same
increase was shown with the hydrolysis products o f PX as well. Yet, repeated doses of
50 pM PX decreased the basal level o f intracellular calcium over time (Hong et al. 2003).
Clearly PX affects different mechanisms involved in calcium signaling pathways and the
homeostasis o f intracellular calcium.
PX has also been demonstrated to induce apoptosis. A mouse T-lymphocytic
leukemia cell line EL4 was exposed to 10 nM PX for 16 h. Employing a combination o f
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specific caspase inhibitors, it was shown that PX induced apoptosis by disruption o f the
mitochondrial transmembrane potential, which in turn caused the release o f cytochrome c
into the cytosol and subsequent activation o f caspase-9 (Saleh et al. 2003). Caspase-9
then cleaved the effector caspase-3 which began the downstream events o f apoptosis.
OPs have also been implicated in producing reactive oxygen species (ROS) which
induces oxidative stress and a cellular response. ROS are either free radicals, reactive
anions containing oxygen atoms, or molecules containing oxygen atoms that can produce
free radicals or are chemically activated by them. The main damage to cells results from
the ROS-induced alteration o f macromolecules such as polyunsaturated fatty acids in
membrane lipids, essential proteins, and DNA. Lipid peroxidation has been suggested as
the molecular mechanism involved in OP oxidative stress (Khrer 1993). When oxidative
stress occurs, a large number o f different ROS scavenging enzymes are released to
remove the oxidative free radicals. Clinical studies o f malathion-exposed patients
detected increased levels o f free radical scavenging enzymes superoxide dismutase,
catalase, glutathione peroxidase, glutathione-S-transferase and gamma glutamyl
transpeptidase enzymes in blood samples in comparison to control (Banerjee et al. 1999;
Seth et al. 2001). OP induced lipid peroxidation has also been demonstrated in rat brains
and human erythrocytes (Gultekin 2000; Verma 2001).
Immune responses: The elimination and/or inactivation of foreign bodies in a
biological system are performed by the immune system. The immune system is
composed o f adaptive (have memory) and innate (no memory) elements (Alberts 2002).
Innate immune responses are not specific to a particular pathogen and rely on proteins
and phagocytic cells to recognize conserved features o f pathogens and become quickly
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activated to help destroy invaders. The adaptive immune response is a more specialized
response that has the ability to recognize and remember foreign pathogens and synthesize
antibody molecules that react specifically to destroy or inactivate the stimulating
pathogen (antigen). There is a large body o f evidence that illustrates the capability o f
OPs to cause immunotoxicity, which is defined as an adverse effect on the immune
system or its component parts. Research using animal models has demonstrated two
general characteristics o f the immune response after OP exposure. Acute doses to
animals that cause cholinergic toxicity show decreased immune function within the
animal. Low doses o f OPs that do not inhibit AChE, produce enhanced immune function
(Pruett 1992). While it is generally difficult to identify the exact molecular targets and
mechanisms o f OP immunotoxicity, it is most likely a combination o f immune system
targets that elicits the immunotoxic effect. Serine hydrolases are involved in the
thrombin systems of the immune system and different esterases are associated with the
cellular membranes o f immune system lymphocytes and monocytes (Stepanovic 1998).
The inhibition of these serine hydrolases and esterases could potentiate the effects o f OPinduced immunotoxicity (Galloway and Handy 2003). OPs could also possibly cause
oxidative stress to lymphoid tissues or different immune organs. Indirect effects on the
immime system could be propagated by altered cholinergic output to different lymphoid
organs as well as a chronic OP toxicity causing changed metabolism followed by
malnutrition and subsequent immunodépression (Galloway and Handy 2003).
The cytokine IL -1P is one of several cytokines involved in inflammation and the
immune response. Elevated levels of IL -ip are associated with both injury and illness.
Rats injected with soman (1 x LD50), showed increased IL -lp mRNA and protein levels
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30 min and 6 h, respectively, post-exposure (Svensson et al. 2001). The highly reactive
nature o f OPs is able to induce a multitude o f different effects within an organism to
cause immunotoxicity.
Cognitive defects: Long-term cognitive deficits have also been shown to be
associated with OP exposure. The cessation o f cholinergic toxicity following OP insult
can be followed by a so called “intermediate syndrome”, OPIDN, or the possibility of
some type o f neurological cognitive deficit. This third type o f neurotoxic action o f OPs
has just recently been named organophosphate-induced chronic neurotoxicity (OPICN)
(Damodaran et al. 2006). OPICN symptoms have been characterized in response to large
and sub-clinical doses o f OPs. Specific examples of OPICN have occurred in victims of
the sarin attacks on the subways o f Tokyo and in veterans o f the first Gulf War who were
suspected o f low level exposure to sarin (Damodaran et al. 2006). While no specific
targets have been linked, there are many clinical cases of victims o f OP exposure that
show a definite cognitive defect. The results from several studies have demonstrated the
presence of OP-induced learning impairments, loss o f concentration, depression, and
difficulty in forming memories (Prendergast et al. 1998; Stone et al. 2000; Rusyniak and
Nanagas 2004). The pathology o f these cognitive deficits has yet to be clearly
demonstrated; current theories include the down regulation o f either cholinergic and noncholinergic receptors (cholinergic receptors involved in memory formation), neuronal cell
death, or some other unidentified brain proteins affected by OPs (Rusyniak and Nanagas
2004).
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Summary

The reaction o f OPs with AChE and the cholinergic toxicity that follows is fairly
well characterized. In general the neurotoxicity post OP insult is attributed to the
inhibition o f AChE. However, three other developed clinical syndromes have been
attributed to OP exposure and cannot solely be explained by AChE inhibition. The so
called “intermediate syndrome”, organophosphate-induced delayed neuropathy (OPIDN),
and the neurotoxic cognitive deficit OPICN have been the subject o f different studies, yet
the precise mechanism and pathways affected that bring about the clinical symptoms are
still unclear. The characterization o f the mechanism o f OPs phosphorylating the active
site serine o f AChE, brought about the realization that OPs might also be targeting
secondary biomolecules in the cell including other serine hydrolases and esterases, as
well as yet unidentified protein and/or pathways. Further investigations into secondary
targets o f OPs uncovered a number o f different non-AChE targets within the cell,
including cholinergic receptors and other specific protein products (as described above).
However, the discovery o f these secondary targets did little to further the understanding
o f non-cholinergic toxicity following OP insult. A clearer understanding of cellular
pathways affected by OPs and the different mechanisms by which OPs cause toxicity is
needed.
The wide use o f OPs as insecticides in both the agricultural and urban setting will
continue for the foreseeable future (Costa 2006). OPs are relatively inexpensive and have
low bioaccumulation within the ecosystem. However, because OPs are not selective,
human exposure is o f concern and research into the targets and mechanisms o f OP
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toxicity outside o f cholinergic hyperstimulation is desirable. The work introduced in this
study begins to address these current issues in organophosphate toxicology. Initially, an
analysis o f gene expression changes in response to an acute, low-dose of the
organophosphate paraoxon was performed using cDNA microarray and SH-SY5Y human
neuroblastoma cells. The next phase o f research involved confirming gene expression
changes using more traditional techniques such as RT-PCR and immunoblot. Following
confirmation o f genes, gene data from the microarray experiments were organized into
groups designated by a set o f genes involved in specific cellular pathways. Additional
experiments were devised to test the modulation o f these pathways by paraoxon.
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Chapter 3
O BJEC TIV ES / SPE C IFIC AIM S

1.

Identify and compare reproducible changes in gene expression following an acute,
low dose, organophosphate (paraoxon (PX), vehicle) exposure to a human
neuroblastoma cell line, identified by cDNA microarray with an in-house human
tox cDNA chip.

2.

Confirm a select gene expression (genes involved in a certain cellular pathway
such as apoptosis or proliferation) change from Aim 1 by semi-quantitative
reverse transcription polymerase chain reaction (RT-PCR), protein analysis,
and/or enzyme activity assay.

3.

Experimentally test the hypothesis that a specific cellular pathway (identified
from microarray data in Aim 1) has been affected by exposure to PX.
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Chapter 4
METHODS AND MATERIALS

Cell Culture:

SH-SY5Y human neuroblastoma cells (ATCC) were maintained in DMEM/F-12
(Dulbecco’s Medium: Ham’s F-12, 1:1 mix) medium supplemented with 10% (v/v) fetal
bovine serum (FBS), 60mg/l (100 U/ml) penicillin and 100 mg/1 streptomycin, in a
Forma Scientific Incubator at 37° C in a humidified atmosphere o f 95% air, 5% CO 2 .
Cells were grown in monolayer culture and harvested at confluence for further passage
by standard cell culture techniques. Cells were harvested using 0.05% trypsin/0.53 mM
EDTA in HBSS.

Paraoxon (PX) Treatment:

Treatment was performed on SH-SY5Y cells in passages 4-8. Paraoxon (98.6%
purity) was purchased from ChemService (West Chester, PA) and was diluted to working
concentrations in acetone. Cells were treated with either 10 nM PX or acetone (0.1%)
alone as a vehicle control.
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Microarray Analysis;

RNA purification: SH-SY5Y cells were passed into T-75 flasks at a density of
1x1 o’ cells/flask and allowed to incubate 48 h prior to treatment. Cells were exposed to
10 nM PX or acetone control and RNA was harvested at three specific time-points- 3, 8,
and 24 h. Each PX-treated flask had a corresponding control flask treated with acetone
for the exact same time. Cells were harvested by scraping and RNA extracted and
purified with the RNeasy Mini Kit (Qiagen, Valencia, CA). Following purification o f the
RNA, spectrophotometer measurements (NanoDrop ND-1000, NanoDrop Technologies,
Wilmington, DE) were made and only RNA with a 260/280 ratio o f 1.9-2.1 was used in
the microarray analysis.

Conversion o f RNA to fluorescentlv labeled cDNA: Conversion o f the RNA to
fluorescently labeled cDNA was carried out using the Superscript Plus Direct cDNA
Labeling System (Invitrogen, Carlsbad, CA). Briefly, 10 pg of RNA was incubated with
5 pg o f Oligo(dX ) 2 0 primer at 70®C for 10 min and then placed on ice. Following
incubation, the RNA-Oligo mix was added to First-Strand buffer (final concentration= 50
mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCW, 0.01 M DTT, Nucleotide Mix
(mixture o f dCTP, dGTP, dATP, dTTP, and labeled dUTP in 10 mM Tris (pH 8.0), 1 mM
EDTA), 40 U o f RNaseOUT, and 800 U o f Superscript III RT. PX-treated RNA was
incubated with Alexa Fluor 647-aha-dUTP Nucleotide Mix while the control RNA was
incubated with Alexa Fluor 555-aha-dUTP Nucleotide Mix, for three h at 46°C. The
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labeled cDNA was then purified and checked for labeling efficiency using the Nanodrop
spectrophotometer.

Hybridization: Analysis was performed for each time-point in duplicate using an inhouse Human Toxicology cDNA Microarray Chip (version 3, Dr. Mark Pershouse Lab,
University o f Montana, Missoula, MT) that contained approximately 1600 unique
cDNA’s (each slide printed with 6 replicate spots o f each gene) of genes generally
implicated in a toxic insult. Labeled probes were denatured for 2 min at 95°C, snap
cooled on ice, and then added to the Human Tox microarray chip and allowed to
hybridize overnight at either 42**C or 50°C. The hybridized slides were quickly agitated
in IX SSC, 0.01% SDS, followed by a) 2X two min washes in IX SSC, and b) 2X two
min washes in 10 mM TE. Washed slides were quickly dried by centrifugation and
stored in a dark box until they were ready to be scanned.

Scanning and Data Analysis: Hybridized microarray slides were scanned using the Gene
Fix 4000B Scanner (Axon Instruments) and the Gene Fix Fro 5.1 software (Axon
Instruments). The data from each scanned digital image was analyzed using lobion Gene
Traffic (lobion Stratagene Analysis Software, lobion Informatics LLC, Stratagene, La
Jolla, CA). Initially, data was normalized to a total 1:1 red to green ratio for the entire
slide. Data were then filtered based on replicate quality, signal intensity, and signal-tobackground ratios of 1.2 or higher. An arbitrary cutoff o f 1.5 fold upregulation and 1.4
fold downregulation was used to select genes o f interest.
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Semi-Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR):

RNA purification was carried out following the same protocol used for the
microarray analysis. cDNA synthesis o f the RNA was done according to the protocol
provided in the Superscript III First-Strand Synthesis System for RT-PCR kit
(Invitrogen). Briefly, 2 pg o f RNA was combined with 5 pM oligo(dX)2 o, ImM dNTP
mix and incubated at 65®C for 5 min followed by 1 min on ice. With the tube on ice, the
following were added: RT buffer (20 mM Tris-HCl pH 8.4, 50 mM KCl), 5 mM MgClz,
10 mM DTT, 40 U RNaseOUT, and 200 U Superscript III RT. After gentle mixing,
reactions were incubated for 50 min at 50®C. Reactions were terminated by heating at
85°C for 5 min and then placed on ice. 2 U o f RNase H were added to each reaction and
allowed to incubate for an additional 20 min at 37°C. cDNA synthesis reactions were
either used for PCR immediately or stored at -20°C.
PCR reactions were carried out in a programmable PTC-200 (Bio-Rad, Hercules,
CA) thermal cycler using Platinum PCR SuperMix (Invitrogen) while following the
accompanying protocol. ECM l, O D Cl, and TUBGl primers were designed using
PrimerQuest software from Integrated DNA Technologies, Inc. p-actin primers were
used to amplify actin as an internal control (Maxim Biotech, Inc., South San Francisco,
CA), and were expected to yield a product of 303 bp. Briefly, reaction tubes contained
10 ng o f cDNA template, 500 nM o f selected primers, and 45 pL o f Platinum PCR
SuperMix (lU complexed recombinant Taq DNA polymerase with Platinum Taq
Antibody, 20 mM Tris-HCl pH 8.4, 50 mM KCl, 1.5 mM M gCh, 200 pM dGTP, 200 pM
dATP, 200 pM dTTP, and 200 pM dCTP). The PCR reactions were cycled as follows: 2
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min at 94°C to activate Taq (1 cycle); 30 sec at 94®C (dénaturation step), 30 sec at 62°
(annealing step, temperature used for all primer sets) and 1 min at 72°C (extension step)
for 30 cycles (all primer sets).
After the PCR reaction, PCR products were electrophoresed alongside a 100 bp
DNA ladder (Promega, Madison, WI) through a 1% (w/v) agarose (Bio-Rad) gel stained
with ethidium bromide. Images were captured using a Kodak DC290 digital camera and
optical density values o f PCR products were quantified using Quantity One software
v.4.2.1 (Bio-Rad). PCR reactions were done in triplicate and statistical analysis was done
with Prism v4.0 software.

Immunoblot analysis:

Treated SH-SY5Y cells were removed by scraping and subsequently lysed for 30
min on ice in lysis buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1% (v/v) Triton X100). Lysate was centrifuged shortly to pellet heavy membranes. Protein concentration
o f the lysate was determined by the BCA method (Pierce, Rockford, IL). All
immunoblots were done in triplicate.

ECM l immunoblot- 15 pg o f protein was loaded onto a 10% PAGE gel (Bio-Rad),
electrophoresed and transferred to PVDF membrane (Bio-Rad). The membrane was, a)
blocked with 2% BSA (Calbiochem, La Jolla, CA) in phosphate buffer saline with Tween
(PBS-T, pH 7.4, Tween 0.1%) for 1 h at room temperature, b) washed in PBS-T for 10
min, c) incubated with rabbit anti-ECMl (1 ; 1000 in block) overnight at 4°C, d) washed
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2X quickly, IX 15 min in PBS-T, e) incubated with donkey anti-rabbit HRP linked
(1:10,000 in block) for 1 h at room temp, f) washed 2X quickly, 1X15 min in PBS-T,
and finally, g) visualized with ECL Plus Western Blotting Detection Reagents (GE
Healthcare, Piscataway, NJ) using a Fujifilm LAS-3000 imaging system (Fuji Photo
Film, Valhalla, NY) and Image Gauge v4.22 software.

ODCl immunoblot- Followed exact same protocol as ECM l Western, with a few
exceptions. 30 pg o f lysate was loaded in each lane and the primary antibody, goat antiODCl (1:500 in block) was incubated for 1 h at room temp. The secondary antibody was
horse anti-goat (1:2000 in block).

Ornithine Decarboxylase (GDC) Activity Assay:

ODC activity was quantified using a modification o f the procedure described by
Coleman and Pegg (Morgan 1997). Cell extracts were lysed in a solution of 10 mM TrisHCl, pH 7.5, 2.5 mM dithiothreitol (DTT), and 0.1 mM EDTA (250 pL). Cells were
frozen and thawed three times followed by centrifugation at 12,000 x gr for 15 min at 4°C
and then placed on ice. 100 pL o f supernatant was combined with 100 pL of lysis buffer
and a 50 pL aliquot o f assay mix (12.5 pL of IM Tris-HCl, pH 7.5, 5 pL of 2 mM
pyridoxal 5'-phosphate, 2.5 pL o f 250 mM dithiothreitol, 5 pL o f 20 mM L-omithine, 2.5
pL o f L-[1-*'*C] ornithine, and 22.5 pL o f deionized water) in a glass assay tube. The
reaction tube was immediately closed with a rubber stopper containing a center well
holding a quarter piece o f a 5.5 cm Whatman filter paper soaked in 1 M NaOH. Tubes
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were allowed to incubate in a shaking water bath for 1 h at 37°C and the reaction was
then stopped by adding 0.25 mL o f 5 M sulfuric acid through the rubber cap. After a
further 1 h incubation, the filter paper was removed and placed in 3 mL o f scintillation
liquid plus 25 pL o f 17 M glacial acetic acid (to reduce lumex number) and counted in a
scintillation counter. 30 pL o f remaining cell lysate was TCA precipitated and then
subject to BCA assay to determine protein concentration. Data were calculated as
nanomoles o f CO 2 per milligram protein per hour.

Cell Proliferation Assays:

Cell Counting- SH-SY5Y cells were passed into a 6 well plate at 1x10^ cells/well and
allowed to adhere for 48 h. Cells were exposed to 10 nM PX or acetone control in
triplicate. Cells were allowed to incubate for 6 days before harvesting. At 6 days post
treatment, media was removed, cells were washed in PBS, and next, 0.75 mL o f trypsin
was added to each well and plate was incubated for an additional 5 min. 0.75 mL o f PBS
was added to each well and the contents o f each well were removed and placed in a
microcentrifuge tube. 35 pL o f cell/PBS/trypsin solution was combined with 35 pL o f
trypan blue, mixed, placed on a hemacytometer, and counted. Three separate areas of the
hemacytometer were counted and recorded for each well.

MTT Assay- SH-SY5Y cells were passed into a 96 well plate at 2 different densities (1
and 3x10'^) in 200 pL o f media/well and allowed to adhere for 48 h. Two different
concentrations of PX (10 nM and 1 nM) or acetone (control) were added to the cells. For
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each cell density and each concentration o f PX, 3 wells o f cells were treated along with 3
wells o f acetone-treated cells, for a total o f 24 wells treated per experiment. For each cell
density, the different concentration o f PX-treated cell counts were compared to the total
acetone treated cell counts (3 wells o f PX vs. 6 wells o f acetone for each cell density). At
96 h post PX treatment, the MTT assay (Roche, Indianapolis, IN) was performed using
the accompanying protocol. Briefly, 20 pL o f MTT labeling reagent (final concentration
0.5 mg/mL) was added to each well. The plate was incubated in a humidified incubator
(same as cell culture above) for 4 h following labeling. Next, 100 pL of Solubilization
solution was added to each well and the plate was again placed in the humidified
incubator overnight. The plate was read on a microplate reader at 560 nm with a
reference wavelength o f 690 nm.

Materials:

Cell culture media was purchased from ATCC (Manassas, VA). FBS, antibiotics,
and trypsin were purchased from Invitrogen. Trypan blue, EDTA, L-omithine, and
pyridoxal 5’-phosphate were all obtained from Sigma (St. Louis, MO). L-[1-^"^C]
ornithine hydrochloride was purchased from GE Healthcare. The anti-ECMl polyclonal
antibody was provided by Professor Lurong Zhang at the University o f Roehester. AntiODC antibody was purchased from Santa Cruz Biotechnology Inc (Santa Cruz, CA).
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Chapter 5
Transcriptional changes in the SH-SY5Y human neuroblastoma cells following
acute, low-dose exposures to the organophosphate paraoxon

Introduction

Microarray technology allows the rapid and quantitative analysis of gene
expression patterns within a cell or area o f tissue. Microarray allows researchers to
survey gene expression changes o f entire genomes in different species including human,
mouse, and yeast. The use o f microarray technology in experiments has been applied to
many different areas o f research including genotyping, development, human disease,
drug discovery, and notably, the field o f toxicology (Afshari et al. 1999; Schena 2003;
Newton et al. 2004). Within the field o f toxicology, microarray is used as a screening
tool for the identification o f molecular targets and mechanisms of toxicity. A review by
Vrana et al. states that microarray “enables researchers to identify those genes and their
products (either single or whole pathways) that are involved in conferring resistance or
sensitivity to toxic substances” (Vrana et al. 2003).
The SH-SY5Y human neuroblastoma cell line, with an adrenergic neuronal
phenotype and expression o f relatively high levels o f AChE and NTE, has been used in
numerous toxicological studies as well as a model system for OP toxicity testing (Ehrich
1995; Veronesi et al. 1997; Barber and Ehrich 2001; Hong et ai. 2003). Gene expression
patterns have also been characterized in SH-SY5Y cell lines using microarray, following
treatment with a wide variety of compounds including ethanol, nicotine, tunicamycin (an
inhibitor o f glycosylation), and the Parkinson’s disease causing metabolite MPP^ (1-
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Methyl-4-Phenyl-Pyridinium) (Conn et al. 2002; Dnnckley and Lukas 2003; Hassan et al.
2003; Reimertz et al. 2003; Hoemdli et al. 2004).
The work presented in this chapter details the transcriptional changes in human
neuroblastoma cells (SH-SY5Y) following a time-course o f acute, low-dose exposures to
the organophosphate paraoxon, measured by cDNA microarray. Data analysis of
genomic changes was further examined using the GoMiner software (available at
http://discover.nci.nih.gov/gominerA. GoMiner is a tool used to gain insight into the
biological relevance o f transcriptional changes within an experiment. The findings
presented in this chapter will help to begin to understand and define the pathways and
different cellular targets modified by OP exposure.

Results

To assess the extent to which the OP paraoxon (PX) modulates gene expression in
neuronal cells, transcriptional changes were monitored using an in-house. Human
Toxicology microarray chip (Mark Pershouse Laboratory, University o f Montana)
containing approximately 1600 different genes. The genes represented on the Human
Tox chip have defined functions in basic cellular processes as well as roles in specific
responses to different types o f toxic insult. While these genes are not representative of
the entire genome, they do provide a foundation for certain pathways or targets affected
by OPs. RNA was isolated from SH-SY5Y neuroblastoma cells treated for 3, 8, and 24 h
with 10 nM PX or acetone vehicle. Previous experimental data using OPs has come
under criticism for the unrealistically large amount of OP that was needed to observe any
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significant change in protein levels (Ray and Richards 2001). The documented cases o f
OP poisoning usually exhibit some degree o f cholinergic toxicity, but there are a
significant number o f undocumented cases that are exposed to substantially lower
concentrations of OP. Although concentrations o f OPs in the blood may reach
micromolar range following a severe poisoning, the target tissues and cellular proteins
and pathways being perturbed by the OP are most likely due to much lower
concentrations (Sun et al. 2000). The fact that OPs show low environmental persistence
due to biodégradation has led to the belief that many o f the toxic effects o f OPs are due to
acute rather than chronic exposures (Casida and Quistad 2004). It was for these reasons
that a low-dose (10 nM), acute (3, 8, 24 hr) exposure o f PX was used.
The use of cDNA as targets on the microarray chip affords greater ability to
observe low abundance mRNA’s. However, with the long length o f the cDNA probes
compared to oligo probes, what is made up in targeting lower abundance mRNA’s is lost
in specificity. A higher hybridization temperature creates more specificity between target
and probe, yet reduces the amount o f probe-target hybridizations. For this reason,
fluorescently labeled cDNA was hybridized with the chip at two different temperatures,
42° and 50°, each done in duplicate, for a total o f four microarray slides per time-point.
On the Human Tox microarray chip, each gene is spotted six times on the slide, with two
different areas being spotted, and each area done in triplicate. After normalization and
background reduction, genes of interest were selected using an arbitrary cut-off o f at least
1.5 fold or greater up regulation, 1.4 fold or greater down-regulation, and at least 5 or
more valid spots of the 24 total spots. While a total o f 24 spots were available for each
gene, the combination of some genes not hybridizing at the higher temperature (loss o f 12
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spots) and the loss o f occasional valid spots due to user manipulation during the
experiment resulted in the use o f 5 or greater valid spots as the cut-off. Microarray data
analysis revealed a total o f 15,49, and 26 genes up-regulated after 3, 8, and 24 h o f 10
nM PX treatment using these filters, respectively. The number of down-regulated genes
compared to control was 6, 9, and 7 for each successive time-point. Table 5.1 provides a
list o f differentially expressed genes following PX exposure.

Table 5.1 Up- and downregulated genes in SH-SY5Y cells after exposure to 10 nM
PX

Genes marked with a (3,8) showed up- or downregulation at the 3 and 8 h time points
Genes marked with a (8,24) showed up- or downregulation at the 8 and 24 h time points
Genes marked with a (3,8,24) showed up- or downregulation at all time points (3, 8, 24 h)
Genes marked with a (3,24) showed up- or downregulation at the 3 and 24 h time points
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3 h 10 nM PX Upregulated genes
Gene ID

Gene nam e

Valid Snots

Fold C hange STDEV

Time Points

R34002
ISGF3G
5
2.2
0.68
Interferon-stimulated transcription factor 3, gamma 48kDa
AA099195
GDI2
5
0.34
2
GDP dissociation inhibitor 2
AA033966
CYP2C8
11
1.9
0.43
(3,8,24)
Cytochrome P450, fam ily 2, subfamily C, polypeptide 8
R72075
NRG l
6
1.8
0.6
Neuregulin 1
N62663
KDELR
7
1.7
0.23
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2
AA004204
COL5A2
9
(3,8)
1.65
0.31
Collagen, type V, alpha 2
R78620
CXCR4
13
1.65
0.58
(3,8)
(C-X-C m o tif receptor 4
R2324I
SOCS2
5
1.6
0.41
Suppressor o f cytokine signaling 2
W44542
GNAIl
13
1.6
0.44
(3,8,24)
Guanine nucleotide binding protein (G protein), alpha inhibiting activity
polypeptide 1
AA029292
OXTR
8
1.5
0.21
Oxytocin receptor
1.5
0.14
AAl 00835
RAP80
6
Receptor associated protein 80
1.5
0.32
AI381503
IL5RA
7
(3,8)
Interleukin 5 receptor, alpha
1.5
0.25
H44575
DST
7
Dystonin
1.5
0.25
N79484
ECMl
21
(3,8,24)
Extracellular matrix protein 1
1.5
0.29
T86932
GPR65
15
G protein-coupled receptor 65

3 h 10 nM PX Downregulated genes
Gene ID

Gene nam e

Valid Snots

Fold C hange STDEV

-1.7
AA045178
LIGl
9
Ligase I, DNA, ATP-dependent
AA043211
ACSLl
9
-1.5
Acyl-CoA synthetase long-chain fam ily member 1

0.12
0.49
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AA242743
XPA
8
-1.5
0.21
(3,24)
Xeroderma pigmentosum, complementation group A
BG572956
BIRC2
9
-1.5
0.36
(3,24)
Baculoviral lA P repeat-containing 2
AA046463
DHPS
9
-1.4
0.19
Deoxyhypusine synthase
AA028080 AKT3
9
-1.4
0.2
V-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)

8 h 10 nM PX Upregulated genes
Gene ID

Gene name

Valid Spots

Fold Change STDEV

Time Points

AA033966 CYP2C8
9
3.7
0.41
(3,8,24)
Cytochrome P450, fam ily 2, subfamily C, polypeptide 8
R78620
CXCR4
14
2.7
0.46
(3,8)
Chemokine (C-X-C motif) receptor 4
AA055467 ODCl
22
2.4
0.27
Ornithine decarboxylase 1
AA029766 TAF9
24
2.3
0.3
(8,24)
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associatedfactor,
32kDa
R46574
FCGR2A
10
2.3
0.31
(8,24)
Fc fragment o f IgG, low affinity Ila, receptor (CD32)
W44542
GNAIl
18
2.3
0.23
(3,8,24)
Guanine nucleotide binding protein (G protein), alpha inhibiting activity
polypeptide I
2.2
0.22
W94612
MCM2
22
MCM2 minichromosome maintenance deficient 2, mitotin (S. cerevisiae)
2.2
0.38
AA046039
MYCBP
5
C-myc binding protein
2.2
0.58
N79484
ECMl
20
(3,8,24)
Extracellular matrix protein I
2.2
0.27
AA040600
PRKAGl
5
Protein kinase, AMP-activated, gamma 1 non-catalytic subunit
N95418
FKBP8
11
2.2
0.43
FK506 binding protein 8, 38kDa
R11631
PAK4
21
2.2
0.33
P2I(CDKNlA)-activated kinase 4 (a fam ily o f serine/threonine p21-activating
kinases)
N93133
PML
15
2.1
0.39
Promyelocytic leukemia
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AA03448I
M6PR
20
2.0
0.36
Mannose-6-phosphate receptor (cation dependent)
AA047816
MVD
21
2.0
0.2
Mevalonate (diphospho) decarboxylase
AA044744
SFRS7
24
2.0
0.4
Splicing factor, arginine/serine-rich 7, 35kDa
W47128
CDK9
20
1.9
0.78
Cyclin-dependent kinase 9 (CDC2-related kinase)
AA004204
COL5A2
11
1.8
0.29
(3,8)
Collagen, type V, alpha 2
AI381503
IL5RA
7
1.8
0.64
(3,8)
Interleukin 5 receptor, alpha
AA045751
UBE2A
21
1.8
0.46
Ubiquitin-conjugating enzyme E2A (RAD6 homolog)
AA143571
PRKARIA 23
1.8
0.28
Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific
extinguisher 1)
N68521
MAP2K2
24
1.8
0.4
Mitogen-activated protein kinase kinase 2
AA021574
LAMBl
18
1.7
0.6
Laminin, beta I
AA040721
Taxlin
9
1.7
0.31
Taxlin- high molecular weight B-cell growth factor receptor binding
AA045633
ADFP
9
1.7
0.39
Adipose differentiation-related protein
AA041538
SRF
8
1.7
0.35
Serum response factor (c-fos serum response element-binding transcription
factor)
AAl 13936
CCNBl
12
1.7
0.15
Cyclin B1
H55985
GSTAl
6
1.7
0.25
Glutathione S-transferase A I
1.7
0.29
R59864
DUSP6
18
Dual specificity phosphatase 6
1.6
0.09
AA029584
TFF3
7
Trefoil factor 3 (intestinal)
0.14
1.6
AA055478
LAM A4
9
Laminin, alpha 4
0.26
1.6
AA065228
MYLK
7
Myosin, light polypeptide kinase
0.12
1.6
AA076085
STATl
6
Signal transducer and activator o f transcription 1, 91kDa
0.46
1.6
A A l 56876
TEAD3
6
TEA domain fam ily member 3 (transcriptional enhancer fc
0.19
H13133
KDELR2
9
1.6
(8,24)
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

42
H14890
M ASTl
6
1.6
0.36
Microtubule associated serine/threonine kinase 1
H87394
HMMR
11
1.6
0.31
(8,24)
Hyaluronan-mediated motility receptor (RHAMM)
N35079
IQCBl
12
1.6
0.43
IQ m otif containing B1
N47111
HTR2C
18
1.6
0.44
5-hydroxytryptamine (serotonin) receptor 2C
N62328
GRM3
12
1.6
0.25
(8,24)
Glutamate receptor, metabotropic 3
R78776
PTPRK
12
1.6
0.2
Protein tyrosine phosphatase, receptor type, K
R71212
BM Pl
24
1.5
0.22
Bone morphogenetic protein 1
AA044151
FABP3
6
1.5
0.13
Fatty acid binding protein 3, muscle and heart (mammary-derived growth
inhibitor)
AA044422
DOXl
6
1.5
0.05
DEAD (Asp-Glu-Ala-Asp) box polypeptide I
T57875
PRKCI
7
1.5
0.29
Protein kinase C, iota
AA056736
RBBP7
12
1.5
0.3
Retinoblastoma binding protein 7
W88506
HMOXl
23
1.5
0.26
Heme oxygenase (de cycling) 1

8 h 10 nM PX Downregulated genes
Gene ID

Gene name

Valid Spots

Fold Change STDEV

Time Points

-1.7
AA101409
SFRS3
6
0.26
Splicing factor, arginine/serine-rich 3
-1.6
0.13
AA045178
LIGl
9
(3,8,24)
Ligase I, DNA, ATP-dependent
-1.6
1.45
A A l 26727
HOXA7
7
Homeo box A 7
0.46
-1.6
(8,24)
AA410383
CXCLI3
6
Chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant)
0.49
-1.6
N43826
FYN
9
FYN oncogene related to SRC, FGR, YES (member o f the protein-tyrosine kinase
oncogene fam ily)
-1.6
0.54
R93550
ALDHIBI
7
Aldehyde dehydrogenase 1 family, member B I
0.34
-1.6
W74710
FALZ
5
Fetal Alzheimer antigen
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R37866
IQGAPl
9
-1.5
IQ m o tif containing GTPase activating protein 1
AA054546 CYBA
8
-1.5
Cytochrome b-245, alpha polypeptide

0.29

(8,24)

0.29

(8,24)

24 h 10 nM PX Upregulated genes
Gene ID

Gene name

Valid Spots

Fold Change STDEV

Time Points

N63328
PPP2R2B
23
2.0
0.56
Protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform
W65461
DUSP5
7
1.9
0.29
Dual specificity phosphatase 5
H72722
M TIB
21
1.8
0.29
Metallothionein IB (functional)
R52410
NTRK2
10
1.8
0.37
Neurotrophic tyrosine kinase, receptor, type 2
AA029766 TAF9
21
1.8
0.3
(8,24)
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associatedfactor,
32kDa
N62328
GRM3
10
1.8
0.29
(8,24)
Glutamate receptor, metabotropic 3
H87394
HMMR
11
1.7
0.51
(8,24)
Hyaluronan-mediated motility receptor (RHAMM)
H13133
KDELR2
7
1.7
0.17
(8,24)
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2
W49497
M M Pl
16
1.7
0.6
Matrix metalloproteinase I (interstitial collagenase)
W23995
MSH2
21
1.7
0.37
M utS homolog 2, colon cancer, nonpolyposis type I (E. coli)
R46574
FCGR2A
9
1.6
0.21
(8,24)
Fc fragment o f IgG, low affinity Ila, receptor (CD32)
R87559
GRIN
19
1.6
0.17
Glutamate receptor, ionotropic, N-methyl D-aspartate 1
N50949
SEC22L3
24
1.5
0.16
SEC22 vesicle trafficking protein-like 3 (S. cerevisiae)
N79484
ECMl
18
1.5
0.15
(3,8,24)
Extracellular matrix protein I
R79560
TJPl
24
1.5
0.16
Tight junction protein 1 (zona occludens 1)
R82017
LRPl
19
1.5
0.15
Low density lipoprotein-related protein I (alpha-2-macroglobulin receptor)
T88776
MAP4K2
24
1.5
0.14
Mitogen-activated protein kinase kinase kinase kinase 2
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W44542
GNAIl
17
1.5
0.25
(3,8,24)
Guanine nucleotide binding protein (G protein), alpha inhibiting activity
polypeptide 1
AA010576 DHFR
21
1.5
0.17
Dihydrofolate reductase
AA033966 CYP2C8
20
1.5
0.3
(3,8,24)
Cytochrome P450, fam ily 2, subfamily C, polypeptide 8
AA046892
DADl
24
1.5
0.09
Defender against cell death 1
AA056507 IFRDl
22
1.5
0.22
Interferon-related developmental regulator I
AA059066 ZF
21
1.5
0.19
HCF-binding transcription factor Zhangfei
H57126
CSFIR
24
1.5
0.2
Colony stimulating factor I receptor, form erly McDonough feline sarcoma viral
(v-fms) oncogene homolog
W74060
NR1D2
24
1.5
0.11
Nuclear receptor subfamily 1, group D, member 2
W76604
RAB28
8
1.5
0.16
RAB2S, member RAS oncogene fam ily
W78013
MCM3
18
1.5
0.32
MCM3 minichromosome maintenance deficient 3 (S. cerevisiae)

24 h 10 nM PX Downregulated genes
Gene ID

Gene name

Valid Spots

Fold Change STDEV

AA410383 CXCL13
5
-1.9
0.47
Chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant)
AA054546 CYBA
10
-1.7
0.27
Cytochrome b-245, alpha polypeptide
R37866
IQGAPl
10
-1.6
0.36
IQ m o tif containing GTPase activating protein 1
AA045178 LIGl
12
-1.5
0.12
Ligase I, DNA, ATP-dependent
AA242743 XPA
12
-1.4
0.23
Xeroderma pigmentosum, complementation group A
AI088984
IL27RA
7
-1.4
0.4
Interleukin 27 receptor, alpha
BG572956 BIRC2
12
-1.4
0.22
Baculoviral lAP repeat-containing 2
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Initial microarray data analysis
The data in Table 5.1 represents the list o f genes whose expression were
considered significantly altered following PX exposure for 3, 8, and 24 h. The validity of
each gene was initially assessed on the number o f valid spots on each of the replicate
microarray slides. Further analysis was done on each gene by observing the individual
spots that makeup the data for that gene, including number o f valid spots, fold change,
and standard deviation (STDEV). The STDEV for each gene was computed using the
fold changes o f each valid spot, however, if one or two o f the valid spots showed poor
hybridization, the STDEV increased. Spots that were not considered valid were not
included in the calculation o f STDEV. For this study, the ideal standard deviation for
each gene should be 0.3 or less. In general, the STDEV’s for the selected genes in Table
5.1 are less than 0.3. However, due to variation between each slide that occurred from
user error and because two different hybridization temperatures were used, some o f the
genes showed an unfavorable STDEV (greater than 0.3). Thus, each gene (including
genes with a higher than desirable STDEV) that showed initial promise as being an up- or
downregulated gene was viewed and analyzed individually to ensure that the majority o f
valid spots showed a uniform fold change. Genes that did not present a majority of valid
spots as being up- or downregulated were discarded from the list.
Analysis of the 10 nM PX time-course showed the number o f genes upregulated
increased significantly from the 3 to 8 h time-point. After the 8 h time-point, a small
decrease in the number o f genes upregulated was observed. Due to the low concentration
o f PX used, one would expect to see a sharp increase in the number o f affected genes
after the initial insult by PX followed by a decrease in changed gene number as the cell
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moves back toward homeostasis. This trend was observed for upregulated genes over the
24 h time-course and is shown graphically in figure 5,1.

Figure 5.1
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Figure 5.1. Significant changes in gene expression of SH-SY5Y cells following
exposure to 10 nM PX. Genes listed show at least a 1.5 fold increase and -1.4 fold
decrease compared to control. Total numbers o f upregulated genes show a large increase
from the 3 to 8 h time point with a modest recovery o f normal phenotype by 24 h.
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The number o f down-regulated genes was similar in number at all time-points.
The downregulated genes were also much smaller in number compared to upregulated,
but this has been observed in other toxicology microarray results (Rogers et al. 2004). A
few genes were affected at all three o f the time-points. They included upregulated genes
Cytochrome P450, family 2, subfamily C, polypeptide

8

(CYP2C8), Extracellular matrix

protein 1 (ECM l), and Guanine nucleotide binding protein (G protein), alpha inhibiting
activity polypeptide 1 (GNAIl) and the downregulated gene Ligase I, DNA, ATPdependent (LIGl). A number o f genes also showed significant fold changes in two o f the
three time-points. Three genes were upregulated in both the 3 and

8

h time points, while

there were 5 genes that showed greater than 1.5 fold change in both the

8

and 24 h time

points. Interestingly, using a cutoff o f 1.4 fold upregulation increased the number of
genes that showed upregulation in both

8

and 24 h fi-om 5 genes to 18 genes. Even as the

cell returned to stasis, PX was continuing to modulate a considerable number o f genes.
While simple investigative conclusions can be made with the vast amount of
microarray data, the question remains, what the hell does it all mean? Initial assumptions
about the toxic effect o f PX can be made by simply grouping the list o f genes into general
categories such as “cell cycle”, “structural”, or “transcription factors”. However,
individual genes and their protein products have been shown to exhibit more than one
molecular function as well as being involved in many biological processes within a cell.
Classifying each gene into one category and trying to make hypotheses about what PX is
doing in the cell can result in a shortsighted or incorrect view o f the toxic effect.
The ability to turn an extensive amount o f gene (or protein, etc) data into
biologically relevant and understandable data has been addressed by a number o f groups
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(Vrana et al. 2003). The Gene Ontology (GO) project was initiated so as to develop a set
o f controlled and structured vocabularies to explain genes, gene products, and sequences
for the science community (Ashbumer et al. 2000; (GO) 2006). The ongoing project
continues to develop and update the vocabulary as new scientific discoveries are made.
“The GO project provides an ontological annotation system that enables biologists to
infer knowledge from large amounts o f data” ((GO) 2006). The systematic language used
in describing each o f the genes and/or gene products is comprised of information in three
key areas shared by all organisms; molecular function, biological process and cellular
component. The use o f this functional information in combination with each of the genes
showing differential transcriptional regulation can help emphasize the biological
processes or pathways being modulated within an experiment. A number o f programs
have now been developed to help facilitate and streamline the interpretation o f
microarray data using the GO database. Included in this next section is an interpretation
o f the cDNA microarray data using the GoMiner software program.
Functional analysis of microarray data
GoMiner is a free program package that separates —omic data into biologically
coherent categories using the GO database (Zeeberg et al. 2003). The user enters a list of
all o f the genes from the microarray slide along with a list o f genes that were
experimentally found to be changed in one way or another (up- or downregulated). The
GoMiner output displays the total number o f genes from the microarray slide associated
with each o f the specific GO categories including molecular functions, biological
processes and cellular components. Underneath each o f the category headings is the list
of genes that were up- or down regulated that are associated with that category as
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described by each gene’s ontology. Certain differentially-expressed genes can be located
in numerous categories within molecular functions or biological processes. The GoMiner
output also lists a number describing the relative enrichment (or depletion) o f a certain
category with respect to the marked genes as well as a two-sided /?-value from Fisher's
exact test. The enrichment number starts at one (no enrichment or depletion) and moves
up or down depending on the relative enrichment or depletion o f the marked genes within
each category. The />-value takes into account the number o f total genes (from the user’s
microarray slide) involved in each category and the number o f marked genes in the exact
same category that are either up- or down regulated from the experiment. The null
hypothesis for each category’sp-value states- there is no difference between the
proportion o f flagged genes that fall into the category and the proportion o f flagged genes
that do not fall into the category. In other words, to reject the null hypothesis and
observe a significant p-value means the number o f flagged genes within a certain
category is significant and not due to chance. A representative GoMiner output table is
shown in figure 5.2.
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Figure 5.2
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^ GRIN1(MGI,RGD,UniProt)
8 G r e s p o n s e to ex tra ce llu la r stim u lu s (9 7 93 p 0 13 1.68 p=0.46 2.77 p= 0.16)
a G r e s p o n s e to nutrient leveis (8 8 9 / p 0 11 1.89 p=0.42 3.11 p=0.13)
a G r e s p o n s e to sta rv a tio n (8 8 9 . ’ p u 11 1.89 p=0.42 3.11 p=0.13)
El G fruiting body form ation ( s e n s u DictyosteW da) (4 1 / 89 it 11 ou 3.77 p=0.24 6.23 p=0.03|
a G sig n a l tra n sd u c tio n (404 0 eu p - o . / j 1.31 p = 0 .0 3 1.23 p=O.OS)
t AKT3(MGIJACDJAIR.UniProt)
CD K 9(DD B^,G eneD B JSpom beA IG UJniProt^FIN )
- f CSF1R(MGI,RGO,UniProt,ZFiH)
CXCR4(MGI,RGD,UniProl) 3)
f FCG2A_HUMAN(FCGR2A| - (MGIJtGD,UniProt)
+ GNAI1(MGI,RG0^niProt,ZFiN)
^ GPR6S(MGI,UniProt)
GRM3(MGI,RGD,UniProt)
^ HTR2C(MGI,RGD,UniPrat)
' t ' ILSRA(MGi,RGD^iProt)
t lQGAP1(MGI,UnProt)
' t L A M B I(F B ^iP rot^F IN )
' t OXTR(M GI,RGD^iProt)
^ PAK4(MGI,UniProt)
' t PPP2R2B(RGD,UniProt,ZFIN|
- t PRKAG1(MGI,RGD,UniProt,ZFIN)
' t PRKAR1A(MGI4tGD.ilniProt.ZFIN)
+ SOCS2(MGI,RGO,UniProt)
+ SRF(DDB,MGI,UniProt,ZFiN> 3)
' t STAT1(MGI,RGD^nS>rot^FIN)

Figure 5.2. A representative GoMiner output displaying GO categories under
biological processes and corresponding up- and down regulated genes. The down
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arrows (green) are downregulated genes, while the up (red) arrows are upregulated. The
numbers before the p-value are the relative enrichments for the up- and down regulated
genes.

Using the GoMiner software, the list o f approximately 1600 genes from the
Human Tox Microarray Chip were loaded into the program. In order to gain an overall
insight into the action o f PX on the cell, all o f the up- and downregulated genes from the
three time points were uploaded simultaneously. Also, because o f the limited number of
up- and downregulated genes in each time point, and the large number of GO categories,
the use o f all genes from all time points at one time would result in a more statistically
significant assessment o f altered biological processes. Data was obtained for the up- and
downregulated genes in all three areas o f GO, molecular functions, biological processes,
and cellular components. The GO database defines molecular functions as any activity,
such as binding, transcription, or receptor, at the molecular level. Biological processes
are a series o f events that include one or more molecular functions in order to achieve the
biological process. The ensuing discussion will focus primarily on the biological
processes in the cell that show differential gene transcription levels following PX insult.
Analysis of the GoMiner data resulted in eight biological processes showing
induction of genes associated with those processes following PX exposure. These
processes include cell communication, phosphorus metabolism, cellular proliferation,
cellular lipid metabolism, cellular transport, cell differentiation, cell cycle, and
cytoskeleton organization and biogenesis. The categories in bold are the broad category
headings and are followed by a discussion o f genes affected within the category and/ or
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subcategories. An enrichment value o f 0.0 and corresponding p value o f 1.00 means no
genes were up- or downregulated within that group.

Genes involved in cell communication (upregulated genes, relative enrichment 1.24,
p=0.05, downregulated genes 1.14, p=0.41):
The largest group o f upregulated genes was represented by cellular
communication processes (437 total genes from Human Tox Chip involved in this
process, relative enrichment o f 1.24 for upregulated genes, p-value 0.05, relative
enrichment o f downregulated genes 1.14, p=0.41). This is a broad group that contains
many subcategories and describes such pathways as cell-cell signaling and signal
transduction. The signal transduction subcategory (404 total genes from Human Tox
Chip) showed a p-value o f 0.03 for upregulated genes and a relative enrichment of 1.31.
Among the genes located in this category were Cyclin-dependent kinase 9 (CDK9),
Colony stimulating factor 1 receptor (CSFIR), Chemokine receptor 4 (CXCR4), Guanine
nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 (GNAIl),
G protein-coupled receptor 65 (GPR65), Interleukin 5 receptor, alpha (IL5RA), P21activated kinase 4 (PAK4), and Protein phosphatase 2, regulatory subunit B, beta isoform
(PPP2R2B). Sub-categories of signal transduction that contained upregulated genes
included cell surface receptor linked signal transduction (relative enrichment o f
upregulated genes 1.39, p=0.08), G-protein coupled receptor protein signaling pathway
(enrichment o f upregulated genes 1.62, p=0.16), intracellular signaling cascade
(enrichment o f upregulated genes 1.32, p-0.12, enrichment o f downregulated genes 1.47
p=0.28), and protein kinase cascade (up genes 1.45, p=0.18, down genes 1.72, p=0.33).
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(For a full list o f genes up- or down regulated within each category and subcategory, see
appendix A.) Signal transduction at the cellular level refers to the movement o f signals
from outside the cell to inside as well as intracellular signaling. The signal can be a
simple movement o f ions in and out o f the cell through receptors or channels that can
change electrical potentials and in turn propagate a signal through the cell (Alberts 2002).
Signal transduction can also be a more complex pathway involving the coupling o f
ligand-receptor interactions to many intracellular events. These events include
phosphorylations by tyrosine kinases and/or serine/threonine kinases. Protein
phosphorylations play a critical role in signal transduction and can also change enzyme
activities and protein conformations. The eventual outcome o f signal transduction is an
alteration in cellular activity and changes in the program o f genes expressed within the
responding cells. Phosphorylation is a critical regulator o f signal transduction and the
differential transcription o f genes involved in signal transduction following OP exposure
proposes an interesting hypothesis. PX might be interfering and/or disrupting different
signaling cascades in the cell through unregulated phosphorylation of signaling cascade
(i.e. protein kinase) targets.
Genes involved in phosphorus metabolism (upregulated genes, relative enrichment
1.49, p=0.04, downregulated genes 0.78, p=0.75):
The second major group o f target genes included genes involved in the
phosphorylation and dephosphorylation o f proteins. Many o f these genes generate
protein products that are important in signal transduction. The ability of PX to interfere
with the signal transduction pathways by phosphorylation correlates well with PX
modulation o f genes involved in the phosphorylation and dephosphorylation of signaling
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cascades. Two subcategories o f phosphorus metabolism contained nearly all o f the
changed genes. The first subcategory is protein amino acid dephosphorylation
(upregulated genes 1.37, p=0.38) which included the genes Dual specificity phosphatase
6

(DUSP 6 ), upregulated at the

8

h time point, and Dual specificity phosphatase 5

(DUSP5), which was upregulated at the 24 h time point. The second subcategory is
protein amino acid phosphorylation (upregulated genes 1.48, p=0.08, downregulated
genes 1 .0 0 , p=0.62) that was represented by a large number o f upregulated genes
involved in signal transduction. These genes included Protein kinase C (PRKCI), Protein
kinase, cAMP-dependent, regulatory, type I, alpha (PRKARIA) and Mitogen-activated
protein kinase kinase 2 (MAP2K2), all upregulated at the

8

h time point and Mitogen-

activated protein kinase kinase kinase kinase 2 (MAP4K2) which was upregulated at the
24 h time point. The inclusion o f this biological process lends support to the idea that PX
is phosphorylating targets in addition to AChE.
Genes involved in cell proliferation (upregulated genes 1.20, p=0.31, downregulated
genes 0.00, p=1.00);
Cellular proliferation occurs by way o f a complex collection o f genes, proteins,
and signaling cascades that are stimulated by any o f numerous types of growth factors
and stimulators. A considerable number o f genes involved in cell proliferation were
upregulated in response to PX throughout the 3, 8 , and 24 h PX exposure time. They
included Mannose-6 -phosphate receptor (M 6 PR), Interleukin 5 receptor, alpha (IL5RA),
and Low density lipoprotein-related protein 1 (LRPl). Further analysis o f genes
associated with cell proliferation noted both Ornithine decarboxylase (ODCl) and ECMl
as genes involved with proliferation but that were not included on the GoMiner list. The
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majority o f OP studies measuring ceil proliferation after OP exposure show decreases in
proliferation after a toxic dose (high concentration, micro- to millimolar) o f OP (Mileson
et al. 1998; Carlson et al. 2000; Guizzetti et al. 2005). However, studies have not been
done correlating low dose OP exposure and cell proliferation. The hypothesis that lowlevel exposure to OP’s is implicated in cancer development (McDuffie 1994; Fritschi et
al. 2005; Gwinn et al. 2005) could possibly be supported by the upregulation o f genes in
this group.
Genes involved in cellular lipid metabolism (upregulated genes 1.57, p=0.21,
downregulated genes 1.49, p=0.50);
Members o f this group were divided into two subcategories o f cellular lipid
metabolism, fatty acid metabolism (upregulated 2.26, p=0.14, downregulated 3.57,
p=0.25) and lipid biosynthesis (upregulated 4.02, p=0.01). The majority o f genes in this
biological process were all upregulated during the

8

h time point. However, this group

illustrates a possible problem in using the p values firom GoMiner in determining whether
or not there is a significant change to a certain biological process. The subcategory of
lipid biosynthesis is made up o f a possible 15 genes from the Human Tox Chip. Only
two o f these genes showed an upregulation, yet this resulted in a p value o f 0.01. When a
chip is designed that carries only a small number o f genes within a certain category, a
smaller number of up- or downregulated genes is needed to produce a significant p value.
Caution should be used in interpreting biological classes seemingly affected by
experimental treatment in relation to the types o f genes that are contained on the
microarray chip. This being said, the inhibition o f carboxylesterases (esterases involved
in cholesterol homeostasis and fatty acid metabolism, (Redinbo and Potter 2005)) by PX
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might have secondarily caused the upregulation of these genes involved in cellular lipid
metabolism.
Genes involved in cellular transport (upregulated genes 1.36, p=0.07, downregulated
genes 0.61, p=0.87):
Cellular transport is another broad biological process that encompasses many
different types o f transport. Cellular transport can involve the movement o f ions,
electrons, chemical compounds, lipids, and proteins, within and in and out o f the cell as
well as genes involved in the regulation o f cell transport. A significant number o f genes
were shown to be part o f two different subcategories o f cell transport. The first
subcategory is intracellular protein transport (upregulated genes 1.46, p=0.22) and
contained KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2
(KDELR2), that was upregulated in the

8

and 24 h time point, and Mannose-6 -phosphate

receptor (M 6 PR), a gene that is also shown to be involved in cellular proliferation. The
second subcategory o f cellular transport shown to have differentially transcribed genes
was vesicle mediated transport (upregulated genes 2.74, p=0.01). The three genes listed
by GoMiner for this biological process were SEC22 vesicle trafficking protein-like 3
(SEC22L3, 24 h), GDP dissociation inhibitor 2 (GDI2, 3 h), and Protein kinase C
(PRKCI,

8

h). Vesicle mediated transport could be essential to cell survival through the

removal o f PX inhibited proteins or in the removal o f PX alone.
The genes associated with cell differentiation (upregulated genes 1.23, p=0.25,
downregulated genes 0.45, p=0.91), cell cycle (upregulated genes 1.08, p=0.43,
downregulated genes 0.78, p=0.75), and cytoskeleton organization and biogenesis
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(upregulated genes 1.55, p=0.16, downregulated genes 0.00, p=I.OO) can be viewed in
appendix A.

Discussion

In this analysis we used Human Tox cDNA microarrays to zinalyze transcriptional
changes during low-level, acute PX exposure in human SH-SY5Y neuroblastoma cells.
Exposing the cells at three different time points (3, 8 , 24 h) resulted in an increase of
upregulated genes from the 3 to
from the

8

8

h time point and a modest decrease o f altered genes

h to 24 h time point. The number o f downregulated genes was considerably

less than upregulated genes and did not show a change in gene numbers throughout the
time course. The majority o f differentially altered genes (Table 5.1) showed minor but
significant fold changes in the range o f 1.5 and 2.0 for upregulated genes and -1.4 and 2 .0

for downregulated genes.
Further analysis o f genes was performed using the Gene Ontology database and

the software program GoMiner. GoMiner compares the up- and downregulated genes
from an experiment to the total genes from the microarray chip and groups the altered
genes into biological processes or molecular functions depending on the unique
ontologies o f each gene. GoMiner produced eight different biological processes that PX
might be modulating after exposure. These different processes involving up- and/or
downregulated genes from the microarray experiments include cell communication,
phosphorus metabolism, cellular proliferation, cellular lipid metabolism, cellular
transport, cell differentiation, cell cycle, and cytoskeleton organization and biogenesis. A
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considerable number o f upregulated genes were grouped into cell communication,
phosphorus metabolism, and cell proliferation.
Two recent studies have also investigated gene expression patterns following OP
exposure using microarray. Changes in gene expression were measured in rats injected
with sarin at an early time point o f 15 min (0.5 x LD 5 0 ) and a later time point o f 3 months
(1

X LD 5 0 ), using a 1200 oligo gene chip geared toward functional and structural groups

relevant to the nervous system (Damodaran et al. 2006). The early time point identified
genes involved in ion channel, cytoskeletal, cell adhesion molecules, transporters, and Gprotein coupled receptors. At three months, up- and downregulated genes were classified
as calcium channel and binding proteins, cytoskeletal and cell adhesion molecules, and
GABAergic signaling molecules. Differential gene expression has also been measured in
human mammary epithelial cells exposed for 6 and 24 h to low concentrations (0.2
mg/0.1 m^> o f malathion (Gwinn et al. 2005). Genes showing differential expression
after malathion treatment were found to be implicated in carcinogen and steroid
metabolism, DNA replication, and cell cycle replication. These papers and the work
presented in this chapter lend support and continue to build on the hypotheses that OPs
target non-AChE-associated cellular pathways and further our understanding of the
mechanisms o f cellular toxicity.
Microarrays allow measurement and characterization o f entire genomes and
gene expression changes in a single experiment (Newton et al. 2004). However, due to
the variability and possible error involved in microarray experiments, care must be taken
in performing the experiment as well as confirmation o f microarray gene changes by a
secondary method. Possible sources o f error include handling o f RNA during isolation.
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variable amounts o f fluorescent probe added to the RNA, uniformity during the spotting
o f the microarray chip (unequal amounts o f cDNA), problems during hybridization
and/or washing (too much specific probe removed or too little non-specific probe
removed), and error in the data acquisition and analysis. Care was taken to minimize
error at each step, such as measurement o f RNA after isolation (260/280 ratio), and
measurement o f fluorescent labeling using the Nanodrop spectrophotometer. However,
the possibility o f error still exists. Gene changes should be confirmed at the RNA and/or
the protein level. The confirmation o f one-gene-at-a-time complements the discovery
role o f the microarray methodology and ensures greater certainty in the microarray results
(Vrana et al. 2003). The work presented in the next chapter chronicles the experiments
done to confirm certain genes found to be differentially expressed by cDNA microarray.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

60
Chapter 6
Confirmation o f microarray data by semi-quantitative RT-PCR, western
immunoblot and radioactive enzyme assay
Introduction

The power o f microarray technology lies in the ability to monitor and characterize
an extremely large number o f genes and affords the possibility to identify novel genes
involved in pathophysiological signaling pathways (Hoemdli et al. 2004). The increased
power o f microarray is accompanied by amplified possibilities o f errors and false
positives. Increased attention to detail during microarray experiments as well as careful
experimental design is imperative for successful results. However, due to the relatively
early development o f the technology and potential for false positives among the
thousands o f tested genes, confirmation o f individual genes at the mRNA or protein level
must accompany microarray data (Vrana et al. 2003).
Certain limitations are inherent in microarray experiments and are important to
consider when analyzing the data (Vrana et al. 2003). First, microarrays measure relative
amounts o f RNA and not absolute amounts. Furthermore, cDNA microarrays are not
very specific due to the length o f the spotted target cDNAs (generally 500-2000 base
pairs). This problem has been somewhat rectified with the use of oligos (25-50 bp) in
place of cDNAs, however both cDNAs and oligos are not able to differentiate between
alternatively spliced transcripts o f the same gene or highly homologous members of the
same gene family. Another challenge in using microarray is that certain assumptions are
being made about the cellular targets, mechanisms and pathways being affected by a
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certain treatment, yet the microarray is measuring an intermediate step, the mRNA levels,
and not the levels o f functional protein product. Once an mRNA is translated into a
protein (if at all), many different post-translational modifications occur that regulates
function o f a protein. For these reasons and more, it is critical to experimentally confirm
certain genes from the microarray data.
In this chapter, the cDNA microarray results will be attempted to be validated
through confirmation o f certain genes at the mRNA, protein, and enzyme activity level.
These experiments will be carried out using semi-quantitative reverse transcription
polymerase chain reaction (semi-quantitative RT-PCR) to make measurements at the
RNA level, immunoblot to characterize genes at the protein level, and enzyme assays for
analysis into whether transcriptional changes equate into differences in enzyme activity.

Results

Four specific genes were chosen to validate the microarray data. Two genes were
upregulated (the specific reasons for choosing these two genes and further information
about the genes will be explained more thoroughly in the following chapter). Ornithine
decarboxylase 1 (ODCl, upregulated 2.4 fold, 8 h time point), and Extracellular matrix
protein 1 (ECM l, upregulated 1.5, 2.2, and 1.5, at the 3, 8, & 24 h time points
respectively); one gene was chosen as an internal control that showed no fold change at
any o f the time points in the microarray data, y-Tubulin 1 (TUBGl); and the fourth gene
was P-actin (BA), a standard housekeeping gene used as an internal control for the RTPCR (Bustin 2000; Meadus 2003), that was not a target cDNA on the microarray chip.
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Semi-quantitative RT-PCR
Individual gene mRNA levels were determined using semi-quantitative RT-PCR.
The optimal annealing temperatures and the linear range for cycle number and quantity of
template for each gene were determined empirically prior to comparing transcript
amounts o f PX and control treated mRNA. All genes characterized by RT-PCR were
detected in the SH-SY5Y cells. Primers used in the PCR reactions are shown in Table
6.1. Following the RT-PCR reactions, PCR products were electrophoresed with ethidium
bromide and optical densities of the resulting bands were measured and analyzed. Figure
6.1 shows the results o f the semi-quantitative RT-PCR, comparing the optical density
(OD) o f the PX-treated transcript and the OD o f the control-treated transcript.
Analysis o f the RT-PCR data revealed no significant change between mRNA
levels in PX-treated cells and mRNA in control-treated cells at any o f the time points for
any o f the genes, compared to TUBGl and P-actin controls. While elevated levels of PX
transcript seem to be evident at the 8 h time point, they were also apparent in both the
TUBGl and P-actin controls, indicating an increased amount o f total mRNA in the 8 h
PX sample compared to the 8 h control mRNA.
Interestingly, an unidentified band appeared in all o f the electrophoresed ECMl
PCR reactions. The expected bp size o f the ECM l transcript is 547 bp, yet in every
reaction, another band was detected, approximately 100 bp above the expected band,
creating a doublet. Gene sequence and primer analysis o f ECM l ruled out contamination
with genomic DNA as well as the possibility o f the band being one of the known splice
variants. ECM l is a relatively newly discovered gene, with the mouse gene first being
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cloned in 1994 and the human homologue isolated in 1997 (Chan 2004). There are
currently three known splice variants o f ECM l (ECM l a, EC M lb, and ECM lc) showing
differential expression (Fujimoto et al. 2005). This being said, the possibility o f a novel
splice variant that has yet to be characterized is reasonable. Calculations o f the optical
density o f the ECM l doublet showed differential expression compared to the four genes
presented in Figure 6.1. Similar expression o f mRNA levels between PX- and controltreated cells were seen at the 3 and 8 h time points, yet the 24 h time point showed an
approximately 1.3 fold increase o f PX over control, factoring in the TUBGl and p-actin
controls. The mRNA levels o f the second unidentified ECM l band are shown in figure
6.2, However, due to the scope o f the project, further analysis o f this uncharacterized
doublet was not done.

Immunoblot analysis
To validate the mRNA changes characterized by the microarray results, SHSY5Y cells were analyzed by immunoblot for changes in ECM l and ODCl protein
levels following exposure to PX. Equal amounts o f protein lysate were analyzed using an
antibody to ECMl that was provided by Professor Lurong Zhang at the University of
Rochester, and a commercially available antibody against ODCl. After probing with the
primary antibodies, membranes were stripped and re-probed for actin to ensure equal lane
loading. Protein analysis was done with cells treated with 10 nM PX or acetone vehicle
for 6, 12, 24 and 48 h. Optimal antibody and lysate concentrations were determined
empirically prior to final experiments
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A significant increase in ECM l protein level was observed at the 12 and 24 h
time points (Figure 6.3). ECM l showed upregulation o f mRNA expression at the 3, 8,
and 24 h time points in the microarray data. Protein expression o f ECM l was elevated at
the 12 h time point and was maintained through the 24 h time point followed by a return
to control levels by 48 h. Protein analysis of ODC1 was done in a similar fashion as
ECM l. Results from the immunoblots showed no statistically significant changes in
ODC 1 protein levels from 6 h to 48 h (Figure 6.4)

ODCl enzyme activity assay
ODC 1 shows variable amounts o f mRNA, protein and activity levels that do not
always correlate within an experiment. Studies have shown minimal changes in mRNA,
yet large inductions o f protein level and even larger increases in enzyme activity (Lin et
al. 2002). Other studies have observed changes in mRNA level and no changes in protein
and activity (Klekner et al. 2001) while another study found all three to closely correlate
(Mohan et al. 1999). For this reason, very small changes in mRNA as observed in the
microarray data (but not yet confirmed by RT-PCR or immunoblot) might affect the
activity of the enzyme. PX may induce a small upregulation o f the gene (as seen by
microarray) and/or is acting directly on the ODCl protein to modulate enzyme activity.
ODCl enzyme activity was measured following PX exposure using a modified
radioactive enzyme assay (Morgan 1997). Activity of ODCl showed no statistically
significant differences between PX and control treated cells (Figure 6.5).
In general, in-vitro experiments measuring ODCl enzyme activity after treatment
with some type of compound use an average exposure time o f 3 h. Measurements for this
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experiment were done from 4 h up until an 8 h time point, the same time an increase in
mRNA was shown by microarray. However, it is believed modulated protein levels of
OD Cl are always accompanied by uniform changes in enzyme activity (Lin et al. 2002),
which is consistent with the data presented in this chapter.
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Table 6.1 Primer sequences for semi-quantitative RT-PCR

GENE

ODCl

PRIMER SEQUENCES

5’- CTG CTT GAT ATT GGC GGT GGC TTT -3’ (forward)
5’- TCA ACA ATC CGA TCG AGG CCA TCA -3’ (reverse)
Expected product size = 413 bp

ECMl

5’- ATC TGC CTT CCT AAC CGT CAG CAT -3' (forward)
5 ’- AGG CCT TCC ATG TAC AGG TGT GAT -3’ (reverse)
Expected product size = 547 bp

TUBGl

5’- TAG AGG GCT TTG TGC TGT GTC ACT -3’ (forward)
5

,

TGA CCA TGG CGA TGT AGC AGT -3’ (reverse)

Expected product size = 573 bp
p-Actin

Expected product size = 303 bp
(Maxim Biotech, Inc., South San Francisco, CA)

CYP2C8

5’- ATC AGT GTA AGG CAT GTG GCT CCT -3’ (forward)
5’- AAG AGG AGC ATT GAG GAC CGT GTT -3’ (reverse)

LRPl

5’- TAC ACA ATC TTC CGG TCT GTG CCA -3’ (forward)
5’- TCA TCT ACT TTG CCG ACA CCA CCA -3’ (reverse)

HMOXl

5’- CTT GAA CTT GGT GGC ACT GGC AAT -3’ (forward)
5 ’- AGG AGA TTG AGC GCA ACA AGG AGA -3’ (reverse)
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Figure 6.1
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Figure 6,1 Semi-quantitative RT-PCR of O D C l, E C M l, TUBG l, and B-actin genes
at 3 ,8 , and 24 time points. Transcripts measured at each time point were done in
triplicate using lOng o f template and 30 cycles o f PCR. Graph is representative o f two
experiments, each performed in triplicate, carried out with different sets of cDNA.
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Figure 6.2

1.50-

ô 1.000.75X 0.50Ql

0.25-

3hr

8hr

24hr

lOnM PX treatment timepoints
Figure 6.2. mRNA levels of EC M l unidentified 2”**band. Transcripts measured at
each time point were done in triplicate using lOng o f template and 30 cycles of PCR.
Graph is representative o f two experiments performed with different sets o f cDNA.
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Figure 6.3
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Figure 6.3. Immunoblot analysis of E C M l following lOnM PX exposure. Optical
densities (CD) were measured for each band and are graphically represented as (PX CD /
actin CD) / (control CD / actin CD). Data is from three independent experiments. 12
and 24 h time points are statistically significant fold changes at the level of * p < 0.05
(unpaired t test).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

70

Figure 6.4
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Figure 6.4. Immunoblot analysis of O D C l following 10 nM PX exposure. Optical
densities (CD) were measured for each band and are graphically represented as (PX CD /
actin CD) / (control CD / actin CD). Each time point is representative o f three
independent experiments. There were no significant changes between any o f the time
points.
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Figure 6.5
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Figure 6.5. O D C l enzyme activity following exposure to 10 nM PX, Activity o f
ODCl was measured after 4, 5.5, and 8 h o f PX exposure. Data represents experiments
done in duplicate for each time point. The positive control was a 3 h media change prior
to harvesting the cells (shown to strongly increase ODCl activity, (Mattsson et al. 1984)).
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Discussion

The ability o f microarray technology to characterize an immense number o f gene
expressions in one experiment increases the possibility o f error within the experiment,
namely the observation o f false positives. For this reason, the validation o f microarray
data must be done by confirming gene changes by other accepted, well established
techniques. This can include confirming changes from microarray data at the RNA
and/or protein level. The validation o f microarray data presented in Chapter 5 was
addressed by three different methods which included semi-quantitative RT-PCR, western
immunoblot, and a radioactive assay to measure enzyme activity.
The mRNA expression levels of four genes (ECM l, O D C l, TUBGl, and (3-actin)
were measured using semi-quantitative RT-PCR. The results from the experiments
showed no change in expression levels in each o f the three time points for TUBGl
(expected) as well as no change in expression levels o f ECM l and ODCl (not expected,
both genes showed upregulation in the microarray data). Furthur RT-PCR analysis
measured PX and control treated cells mRNA expression o f Cytochrome P450, family 2,
subfamily C, polypeptide 8 (CYP2C8), Low density lipoprotein-related protein 1 (alpha2-macroglobulin receptor) (LRPl), and Heme oxygenase (decycling) 1 (HMOXl).
Again, no changes in expression levels between PX and control treated cells was
observed. There could be any number o f reasons the semi-quantitative results did not
correlate with the microarray data. Because the gene fold changes in the microarray data
were modest, the ability to observe the same modest changes through other methods
becomes difficult and requires greater sensitivity and precision. The use of semi-
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quantitative RT-PCR (sqRT-PCR) has drawn criticism as not being a sensitive enough
method to monitor small changes in mRNA expression (Rajeevan et al. 2001). There is
also the possibility that the cDNA microarray targets hybridized certain known and/or
unknown spice variants, or gene family homologues, o f these upregulated genes and
these splice variants (or homologues) were not enriched using the chosen PCR primers.
The increased expression o f the unidentified 2"** band o f ECMl at 24 h somewhat
supports this hypothesis. Semi-quantitative RT-PCR can show variability in the results
and is prone to error during the many steps firom isolated RNA to electrophoresed PCR
products (Brunner 2004). In some cases, the up- or downregulated genes fi*om the
microarray data are false positives and would therefore show no change by RT-PCR.
The use o f quantitative real-time RT-PCR has alleviated many o f these problems and
would have been a better choice for confirming microarray data. In addition to using
semi-quantitative RT-PCR, upregulated genes ECM l and ODCl were also monitored for
increased protein levels.
Immunoblot analysis o f ECM l and ODCl confirmed the upregulation of the
ECM l gene and gave further proof to the possibility ODCl was a false hit. ECMl
protein expression showed increased levels at 12 and 24 h post PX exposure. The
microarray data shows a slight upregulation at 3 h (1.4 fold), followed by a substantial
increase at 8 h (2.2 fold), and then a decrease at 24 h to 1.5 fold which correlates well
with the protein expression. ODCl protein expression did not change at any time point
after PX exposures. Due to the variability in expression levels o f ODCl gene, protein,
and enzyme activity discussed above, we wanted to make sure to analyze all possible
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areas to either confirm or rule out ODCl as a hit or false positive, and so ODCl was
further characterized with respect to enzyme activity.
The radioactive assay used to measure ODCl activity showed no statistically
significant increase or decrease in enzyme activity after PX insult. Initial failures in
confirming ODCl upregulation by semi-quantitative RT-PCR and western blot were
attributed to two different factors. The first was that ODCl is a highly regulated enzyme
and has a very short half-life, ranging from minutes to an hour (Lin et al. 2002). The
second reason is immortal cells express higher levels o f ODC protein and exhibit
elevated enzyme activity compared to normal tissue or primary cell lines (Hu et al. 2003).
We believed the short half life in addition to high levels o f ODCl protein and activity
(SH-SY5Y is an immortal cell line) was confounding our ability to measure small
differences in either RNA or protein levels. However, after confirming no change in
enzyme activity levels, we were confident in assuming ODCl was a false positive (no
change in RT-PCR, immunoblot, enzyme activity) and did not warrant consideration as
an upregulated gene in response to PX. The work done on ODC 1 emphasizes the
importance in confirming up- and dovraregulated genes following microarray
experiments.
While it is o f utmost importance to confirm individual genes from the microarray
data, the original hypothesis was to identify and characterize pathways, protein targets, or
biological processes that are modulated in some way by the OP paraoxon. The next
chapter specifies the reasons why ECM l and ODCl were chosen as genes to confirm and
details the work done to support the hypothesis that 10 nM PX induces cellular
proliferation.
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Chapter 7
Characterization o f the induction of cellular proliferation by acute, low-dose
paraoxon exposure
Introduction

Microarray technology allows the user to simultaneously monitor thousands of
gene expression levels in one experiment. The next step is organizing the extensive
amounts o f microarray data into intelligible biological data that sets forth different ideas
of what all the gene changes mean. The interpretation o f this data is often the most
difficult step o f a microarray experiment.
There are a number o f programs available that analyze the different up- and
downregulated genes and attempt to produce different pathways or biological processes
that might be modulated in some way. While the organization o f the microarray data into
the different pathways is extremely helpful, it does not establish proof of causation.
Nevertheless, the organization o f this data is advantageous in developing hypotheses
about the nature o f the treatment and its effect on a biological or cellular system. The
next step after carefully reviewing and evaluating the meaningful microarray data is to
design an appropriate set of experiments to test a hypothesis.
The purpose o f the present research was to test the hypothesis that the OP PX
modulated / altered / blocked a unique or novel set o f protein targets or specific cellular
pathways following exposure. Microarray data from SH-SY5Y cells treated with lOnM
PX was further characterized using the GoMiner software to try and identify these
affected targets or pathways. The genomic changes identified by microarray generated
eight possible affected cellular processes organized and elucidated by GoMiner. These
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processes included signal transduction, phosphorus metabolism and cellular proliferation.
With the preponderance o f experimental data showing OPs decrease or inhibit cellular
proliferation at micromolar to millimolar concentrations (Rodriguez and Bustos-Obregon
2000; Guizzetti et al. 2005), we hypothesized that a low concentration (nanomolar) dose
o f PX might actually stimulate proliferation.
After deciding to further investigate the effect o f PX exposure on cellular
proliferation, a more careful analysis was performed on the up- and downregulated genes
to identity any other genes identified in the microarray experiment that might be involved
in cellular proliferation, but were not identified by GoMiner. Two other genes, in
addition to the genes named by GoMiner, Ornithine decarboxylase 1 (ODCl) and
Extracellular matrix protein 1 (ECM l) were classified as genes involved in cellular
proliferation. These were also the two genes that chosen for the validation o f the
microarray results (previous chapter). In addition, both ODCl and ECMl were very
good hits from the microarray data, with a high number of valid spots, low STDEV, and a
significant fold change.
ODCl is a key, rate-limiting enzyme in the biosynthesis o f polyamines in
mammalian cells (Shantz and Pegg 1999; Zhang and Chen 2002; Hu et al. 2003). The
polyamines putrescine, spermidine, and spermine are essential for cellular growth,
differentiation and proliferation (Mohan et al. 1999). Upregulation o f ODCl gene,
protein level, and enzyme activity has been implicated in the induction of cell
proliferation, and ODCl has also been shown to be constitutively expressed at increased
levels in cancer (immortal) cells (Mohan et al. 1999; Klekner et al. 2001 ; Hu et al. 2003).
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The choice o f ECM l as a gene to use to both confirm the microarray data and
characterize its existence in SH-SY5Y cells, is due to its role in proliferation as well as
ECM l being a relatively newly discovered protein. ECM l is a widely expressed
glycoprotein that has been characterized in cell proliferation, angiogenesis,
differentiation, as well as regulation o f basement membrane and growth factor binding
within the skin (Wang et al. 2003; Chan 2004; Lupo et al. 2005). ECM l consists o f three
known splice variants ECM l a, ECM lb, and ECM lc. ECM l a is widely expressed and is
found in various tissues including skin, liver, lung, ovary, prostate, skeletal muscle and
heart. ECM lb on the other hand has only been discovered in tonsils, kératinocytes, and
tissue o f the upper respiratory tract (Fujimoto et al. 2005). ECM lc has yet to be fully
characterized with respect to its distribution and expression, but has been shown to
account for approximately 15% o f skin ECM l RNA (Chan 2004). Protein levels of
ECM l have shown increased expression in malignant epithelial tumors (breast and lung)
(Han et al. 2001; Wang et al. 2003) and have has been used as a diagnostic marker in
malignant thyroid neoplasms (Kebebew et al. 2005).
Because a considerable number of genes (ten) involved in cellular proliferation
showed an upregulation in response to 10 nM PX exposure, experiments were devised to
test the hypothesis that PX causes an increase in proliferation. The data presented in this
chapter documents the experimental work done to prove the idea that exposure to 10 nM
PX induces cellular proliferation.
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Results

In order to assess the potential effect o f 10 nM PX on cellular proliferation,
growing SH-SY5Y cells were used. SH-SY5Y cells have been used previously as in
vitro models to study and characterize neuronal growth (Matthews and Feldman 1996;
Celli et al. 1999). Two different experimental approaches were taken to identify cellular
proliferation; manual cell counting and MTT assay.
The manual cell counting method involved plating cells in

6

well plates and 48 h

later treating with 10 nM PX or acetone control. After 6 days o f PX treatment, cells were
removed from the plate and counted (Figure 7.1). Cells treated with 10 nM PX showed a
significant (p<0.005) increase in cell number compared to cells treated with acetone
vehicle. In general, about a 1.3 —1.4 fold increase in cell number was observed
throughout the replicate experiments. To rule out the possibility that PX was interacting
with a component in the medium, which in turn secondarily caused cell proliferation,
media was pre-treated with 10 nM PX and allowed to incubate at 37°C for 48 h before
addition to the cells. Pre-treatment o f media with PX resulted in no significant (p>0.05)
proliferation relative to control (Figure 7.2).
To supplement and confirm the cell counting experiment, cellular proliferation in
SH-SY5Y cells was also assessed by MTT assay. The MTT assay is a colorimetric assay
that analyzes proliferation by measuring the cleavage product (purple formazan crystals)
o f yellow tétrazolium salt MTT by the mitochondrial enzyme succinic dehydrogenase,
which is active in proliferating cells. SH-SY5Y cells were treated with 10 nM, 1 nM, or
acetone vehicle for 4 days and then analyzed for cellular proliferation using the MTT
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assay. Results are shown in Figure 7.3. The MTT assay showed an approximate increase
in cellular proliferation o f 1.2 fold following 10 nM PX exposure. Treatment o f SHSY5Y cells with 1 nM PX showed no increase in proliferation compared to control.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

80

Figure 7.1
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Figure 7.1. 10 uM PX induces cellular proliferation. SH-SY5Y cells were passed into
a 6 well plate at 1x10® cells/well. Treatment started 48 h post plating. Cells were
counted

6

days after treatment using a hemacytometer. Graph representative of three

experiments, each done in triplicate. ** p<0.005, (impaired t test)
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Figure 7.2
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Figure 7.2. Media pre-treated with 10 nM PX does not induce cellular proliferation.
SH-SY5Y cells were passed into a

6

well plate at 1x10^ cells/well. Media was treated

with 10 nM PX 48 h and allowed to incubate at 37®C before addition to the cells. Cells
were counted

6

days after treatment using a hemacytometer. Graph representative o f two

experiments, each done in triplicate. P>0.05 (unpaired t test)
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Figure 7.3
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Figure 7.3. M easurem ent o f SH-SY5Y cellular proliferation by M TT assay. SHSY5Y cells were passed into a 96 well plate at 1 and 3x1 O'* cells/well. Treatment started
48 h post plating. Cells were measured for proliferation 4 days after treatment using an
MTT assay. Graph representative o f six experiments (three at 1x10* and three at 3x10*
cells/well), each done in triplicate. Similar changes were observed for 1 and 3x10*
cells/well. * p<0.05, (unpaired t test)
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Discussion

Results from the cell counting experiment and MTT assay corroborate our
hypothesis that low dose (10 nM) PX induces cellular proliferation. Two approaches
were used to evaluate cellular proliferation induced by PX. In the first, human
neuroblastoma SH-SY5Y cells showed increased proliferation o f about 1.3-1.4 fold
following a

6

day treatment o f 10 nM PX. The cells also showed a significant (p<0.05)

increase o f 1.2 fold by MTT assay after 4 days o f 10 nM PX exposure. However, the
increase in proliferation was reduced when the concentration o f PX was ten fold less (1
nM). The MTT assay (4 day PX treatment) might have shown a similar fold change to
the cell counting experiment ( 6 day PX treatment) if the PX exposure was carried out an
additional two days. However, the small quantity o f media in the 96 well plate did not
allow for this.
The MTT assay measures the activity o f a mitochondrial enzyme, so it is
appropriate to ask whether OPs directly target mitochondria. Research has shown that
exceedingly high levels (100 fiM - 1 mM) o f OPs hyperpolarize the mitochondrial
transmembrane potential in SH-SY5Y cells (Carlson and Ehrich 1999). However, the
change in potential was not directly correlated to OPs and is possibly the secondary result
o f OP cytotoxicity (apoptosis).
A number of other cell counting experiments were performed to further
characterize cellular proliferation. Media was pre-treated with 10 nM PX and allowed to
incubate at 37®C for 48 h prior to addition to the cells, which resulted in no increase in
cellular proliferation. This experiment ruled out the possibility that PX was reacting with
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components in the media which secondarily caused cellular proliferation. Multiple doses
o f PX throughout the

6

day treatment period were also experimentally examined. The

results o f this experiment again showed no increase in cellular proliferation compared to
control. This might be due to the fact that each successive dose resulted in increased
concentrations o f PX, therefore blocking the proliferation phenotype.
There are different methods to measure cellular proliferation in addition to cell
counting by hemacytometer and MTT assay. Using the same experimental setup as the
cell counting by hemacytometer, SH-SY5Y cells were also counted using a Coulter
Counter. Results from the Coulter Counter were quite varied. In one experiment there
would be induction o f proliferation followed by an experiment that showed no induction
or even a decrease in cellular proliferation. The tendency o f SH-SY5Y cells to aggregate
and form clumps resulted in inconsistent counts with the Coulter Counter. A research
group measuring cellular proliferation in SH-SY5Y cells noted that the MTT assay is the
superior choice for measuring proliferation in this specific cell line (Celli et al. 1999).
A comprehensive literature search uncovered a single paper that investigated low
level OP exposure and cell proliferation. The OP methamidophos stimulated cell
proliferation o f SH-SY5Y by 28% at a concentration of 700 nM, and inhibited
proliferation by 62% after exposure to 7 mM as determined by MTT assay (Li et al.
2003). Calcium uptake was also measured following exposure to methamidophos. SHSY5Y cells showed decrease uptake and markedly increased uptake of calcium at high
and low levels o f methamidophos, respectively. Their conclusion was that
methamidophos was disrupting calcium homeostasis which was leading to the increase or
inhibition of proliferation depending on the concentration o f OP. While the work
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discussed in this chapter shows a similar end result, the data presented here provides
evidence that 10 nM PX is upregulating a number o f cellular proliferation genes resulting
in the induction o f proliferation.
Interestingly, a number o f studies have linked occupational exposure o f OP
pesticides with an increased risk o f non-Hodgkin’s lymphoma (McDuffie 1994; Fritschi
et al. 2005). Another study demonstrated that malathion and parathion (0.167xLDso and
0.5x LD 5 0 , respectively, 2 times daily for 5 days) induced proliferation o f terminal end
buds o f mammary glands followed by formation o f mammary carcinomas in SpragueDawley female rats (Cabello et al. 2001). OPs, as a general class, have not been
characterized as carcinogens, but these studies and the fact that 10 nM PX induces
cellular proliferation support the hypothesis that OPs may be implicated in cancer.
However, caution should be taken in interpreting the in vitro data from this chapter in that
it does not take into account the toxicokinetic factors o f an in vivo model.
The cell cycle is a highly regulated process that is tightly associated with cellular
proliferation. There a large variety o f signals, including growth factors, cytokines, and
mitogens, that induce cells to divide (Alberts 2002). The signals that induce proliferation
are moved through a number o f different signaling pathways that include the MAP
kinase. Protein kinase C, and JAK/STAT pathways (Alberts 2002). Further work would
need to be done to identify if the upregulation o f cellular proliferation genes, and the
increased levels of ECM l protein, are due to direct action o f PX acting as a growth
factor, or are a secondary result o f a target or signaling pathway being modulated by PX,
which in turn leads to an upregulation o f proliferation genes. Also, because this work
was done in an immortal cell line, which already have a number of proliferation genes
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constitutively expressed, additional experiments would need to be done on primary cell
lines to see if low dose PX induces the same phenotype.
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Chapter

8

CONCLUSIONS AND FUTURE WORK

The initial discovery and development o f OPs led to the characterization o f the
main mechanism o f OP toxicity, the inhibition o f AChE. Further work defined the
consequences o f this inhibition, namely cholinergic crisis. Recent research into OPs
toxicity has identified other significant secondary targets and outcomes o f OP exposure
that include OPIDN and OPICN. While the clinical manifestations o f OP exposure,
outside o f AChE inhibition, have been fairly well characterized, the cellular components,
mechanisms and pathways that are involved in the disease’s progressions are obscure.
The work presented in this thesis begins to characterize the possible pathways and targets
altered by OP exposure. Using cDNA microarray, transcriptional changes in the SHSY5Y human neuroblastoma cell line were measured after treatment with 10 nM
paraoxon (PX). The results o f this experiment led to the following conclusion:

•

Acute, low-level exposure to PX induced the up- and downregulation of a

number of genes. Using GoMiner software, it was determined that a number o f different
cellular processes were modulated following PX exposure. Analysis of the GoMiner data
resulted in eight biological processes showing induction o f genes associated with those
processes. These processes include, cell communication, phosphorus metabolism,
cellular proliferation, cellular lipid metabolism, cellular transport, cell differentiation, cell
cycle, and cytoskeleton organization and biogenesis.
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Because OPs have been implicated with the development o f cancer and the fact
that a number of genes from the microarray data were grouped under cellular
proliferation, experiments were devised to test the hypothesis that exposure to 10 nM PX
induces cellular proliferation. The findings o f these experiments are summarized below:

•

10 nM PX exposure induced significant cellular proliferation in SH-SY5Y

hum an neuroblastom a cells. Using two different techniques to measure cellular
proliferation, it was shown that exposure to 10 nM PX induces a small, but significant
proliferation. The MTT assay showed about a 1.2 fold increase in proliferation at 10 nM
PX while 1 nM PX showed no increase. The cell counting experiment measured an
approximately 1.3 fold induction o f cellular proliferation. Further work needs to be done
to fully characterize changes in proliferation at different time points and different
concentrations of PX.

The microarray data in chapter 5 was attempted to be confirmed using a number
o f different techniques including semi-quantitative RT-PCR, immunoblot, and enzyme
activity assay. A unique finding from these confirmation experiments is detailed below:

•

Expression of E C M l in SH-SY5Y hum an neuroblastom as was confirmed by RT-

P C R and im m unoblot. ECM l is a recently discovered protein that has yet to be fully
characterized with respect to its expression. ECM l expression has been identified in a
number of tissues including skin, blood vessels, heart, placenta, tonsils, liver and lung.
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By northern blot, ECM l expression was not detected in brain, but neuroblastomas have
not been tested for ECM l expression. The characterization of ECM l by RT-PCR and
immunoblot in SH-SY5Y confirms the presence o f the gene and protein. Exposure to 10
nM PX induces the increased expression o f protein levels as shown by microarray and
immunoblot.

Overall, the work detailed in this study contributes to an initial understanding o f
gene changes in response to PX exposure. The microarray data presented here resulted
from the use o f a Human Tox cDNA chip. The use o f a full genome oligo microarray
chip would allow the researcher the opportunity to more fully characterize genomic
changes after PX exposure. Additional experiments with different concentrations o f PX,
or different types of OPs, and different time points would also be advantageous in
creating toxic footprints o f all types o f OPs. Examination o f data from different OPs and
concentrations might also identify possible biomarkers of OP exposure. OPs as a class
might upregulate certain genes they all have in common, but also a characteristically
unique set o f genes by which to identify specific OPs. The identification of biomarkers
would be useful in developing screening techniques for OP exposure in humans.
Following the additional microarray work, experiments devised to test specific pathways
and protein targets could lead to a better understanding o f OPs toxicity and clinical
outcomes. Clearly, further work is needed in characterizing the protein targets and
cellular pathways affected by OPs.
The identification o f specific cellular machinery involved with proliferation
following OP exposure is also important. From the work presented here, it is not possible
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to determine whether PX is the primary cause o f proliferation or if proliferation is a
secondary result o f some other PX interaction within the cell. The examination of the
ability o f different OPs to cause proliferation, and the exploration into whether or not
OPs cause proliferation in other cell lines and specific tissues would also need to be
performed.
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